[
  {
    "snippet": "[Sitemap](https://medium.com/sitemap/sitemap.xml)\n\n[Open in app](https://rsci.app.link/?%24canonical_url=https%3A%2F%2Fmedium.com%2Fp%2Fa1ab9e6119fa&%7Efeature=LoOpenInAppButton&%7Echannel=ShowPostUnderCollection&%7Estage=mobileNavBar&source=post_page---top_nav_layout_nav-----------------------------------------)\n\nSign up\n\n[Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2Fmicrobial-instincts%2Fthe-false-alarm-on-rubella-in-texas-was-a-warning-shot-and-we-s...",
    "content": "[Sitemap](https://medium.com/sitemap/sitemap.xml)\n\n[Open in app](https://rsci.app.link/?%24canonical_url=https%3A%2F%2Fmedium.com%2Fp%2Fa1ab9e6119fa&%7Efeature=LoOpenInAppButton&%7Echannel=ShowPostUnderCollection&%7Estage=mobileNavBar&source=post_page---top_nav_layout_nav-----------------------------------------)\n\nSign up\n\n[Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2Fmicrobial-instincts%2Fthe-false-alarm-on-rubella-in-texas-was-a-warning-shot-and-we-should-pay-attention-a1ab9e6119fa&source=post_page---top_nav_layout_nav-----------------------global_nav------------------)\n\n[Medium Logo](https://medium.com/?source=post_page---top_nav_layout_nav-----------------------------------------)\n\n[Write](https://medium.com/m/signin?operation=register&redirect=https%3A%2F%2Fmedium.com%2Fnew-story&source=---top_nav_layout_nav-----------------------new_post_topnav------------------)\n\n[Search](https://medium.com/search?source=post_page---top_nav_layout_nav-----------------------------------------)\n\nSign up\n\n[Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2Fmicrobial-instincts%2Fthe-false-alarm-on-rubella-in-texas-was-a-warning-shot-and-we-should-pay-attention-a1ab9e6119fa&source=post_page---top_nav_layout_nav-----------------------global_nav------------------)\n\n![](https://miro.medium.com/v2/resize:fill:64:64/1*dmbNkD5D-u45r44go_cf0g.png)\n\n[Mastodon](https://me.dm/@epiren)\n\n[**Microbial Instincts**](https://medium.com/microbial-instincts?source=post_page---publication_nav-bd4c58bfa8c9-a1ab9e6119fa---------------------------------------)\n\n·\n\nFollow publication\n\n[![Microbial Instincts](https://miro.medium.com/v2/resize:fill:76:76/1*NYalSuFa9XrlE-kog6De_Q.png)](https://medium.com/microbial-instincts?source=post_page---post_publication_sidebar-bd4c58bfa8c9-a1ab9e6119fa---------------------------------------)\n\nDecoding the microbial angle to health and microbial world.\n\nFollow publication\n\nMember-only story\n\nFeatured\n\n# The False Alarm on Rubella in Texas Was a Warning Shot — And We Should Pay Attention\n\n## Known as “German measles,” rubella is yet another one of those viruses that gives epidemiologists nightmares.\n\n[![René F. Najera, MPH, DrPH](https://miro.medium.com/v2/resize:fill:64:64/1*EXupeNHa0taMS8ga43F8Gw.jpeg)](https://medium.com/@epiren?source=post_page---byline--a1ab9e6119fa---------------------------------------)\n\n[René F. Najera, MPH, DrPH](https://medium.com/@epiren?source=post_page---byline--a1ab9e6119fa---------------------------------------)\n\nFollow\n\n6 min read\n\n·\n\nMar 6, 2025\n\n9\n\nShare\n\nPress enter or click to view image in full size\n\n![The image shows a vintage educational exhibit about rubella, featuring illustrated panels with text and graphics. The left panel asks, “Is her unborn baby safe from rubella?” and shows a healthcare worker examining a pregnant person. Below, a bar chart and an image of an infant discuss congenital rubella syndrome and birth defects. The right panels outline prevention strategies with illustrations of healthcare workers, children, and classroom settings. A sign at the top reads, “STOP THE SPREAD F](https://miro.medium.com/v2/resize:fit:700/1*wvi_L36yT3QH28Yit-ZmOw.jpeg)\n\nIn January 2025, the Texas Department of State Health Services reported an outbreak of measles centered around Gaines County, in the western part of the state. The outbreak spread from there to a bordering county in the state of New Mexico, and to several counties in Texas. But there was a report of a disease that keeps me up at night: [Rubella](https://historyofvaccines.org/diseases/rubella-german-measles).\n\nIf you’re familiar with the MMR vaccine, then you know that the “R” in MMR is for rubella, [a viral disease caused by the rubivirus and often called “German measles.”](https://academic.oup.com/cid/article-abstract/43/Supplement_3/S164/288915?redirectedFrom=fulltext) It used to be _endemic_ in most of the world, meaning that transmission was constantly happening. This was the time before the vaccine.\n\nWorst of all, the disease caused a condition in newborn children called _Congenital Rubella Syndrome_ (CRS), and it was often deadly. In fact, a large pandemic of rubella in the 1960s resulted in many women choosing to end their pregnancies if they developed rubella. By some accounts, [that pandemic triggered the strong discussions on abortion](https://www.sciencehistory.org/stories/distillations-pod/roe-v-wade-v-rubella/) that happened in the United States in the 1960s and 70s.\n\n## Create an account to read the full story.\n\nThe author made this story available to Medium members only.\n\nIf you’re new to Medium, create a new account to read this story on us.\n\n[Continue in app](https://rsci.app.link/?%24canonical_url=https%3A%2F%2Fmedium.com%2Fp%2Fa1ab9e6119fa&%7Efeature=LoOpenInAppButton&%7Echannel=ShowPostUnderCollection&%7Estage=regwall&source=-----a1ab9e6119fa---------------------post_regwall------------------)\n\nOr, continue in mobile web\n\nAlready have an account? [Sign in](https://medium.com/m/signin?operation=login&redirect=https%3A%2F%2Fmedium.com%2Fmicrobial-instincts%2Fthe-false-alarm-on-rubella-in-texas-was-a-warning-shot-and-we-should-pay-attention-a1ab9e6119fa&source=-----a1ab9e6119fa---------------------post_regwall------------------)\n\n[![Microbial Instincts](https://miro.medium.com/v2/resize:fill:96:96/1*NYalSuFa9XrlE-kog6De_Q.png)](https://medium.com/microbial-instincts?source=post_page---post_publication_info--a1ab9e6119fa---------------------------------------)\n\n[![Microbial Instincts](https://miro.medium.com/v2/resize:fill:128:128/1*NYalSuFa9XrlE-kog6De_Q.png)](https://medium.com/microbial-instincts?source=post_page---post_publication_info--a1ab9e6119fa---------------------------------------)\n\nFollow\n\n[**Published in Microbial Instincts**](https://medium.com/microbial-instincts?source=post_page---post_publication_info--a1ab9e6119fa---------------------------------------)\n\n[4K followers](https://medium.com/microbial-instincts/followers?source=post_page---post_publication_info--a1ab9e6119fa---------------------------------------)\n\n· [Last published Nov 3, 2025](https://medium.com/microbial-instincts/everyday-viruses-could-be-priming-our-brain-for-neurodegeneration-over-time-29f4e3854596?source=post_page---post_publication_info--a1ab9e6119fa---------------------------------------)\n\nDecoding the microbial angle to health and microbial world.\n\nFollow\n\n[![René F. Najera, MPH, DrPH](https://miro.medium.com/v2/resize:fill:96:96/1*EXupeNHa0taMS8ga43F8Gw.jpeg)](https://medium.com/@epiren?source=post_page---post_author_info--a1ab9e6119fa---------------------------------------)\n\n[![René F. Najera, MPH, DrPH](https://miro.medium.com/v2/resize:fill:128:128/1*EXupeNHa0taMS8ga43F8Gw.jpeg)](https://medium.com/@epiren?source=post_page---post_author_info--a1ab9e6119fa---------------------------------------)\n\nFollow\n\n[**Written by René F. Najera, MPH, DrPH**](https://medium.com/@epiren?source=post_page---post_author_info--a1ab9e6119fa---------------------------------------)\n\n[3.2K followers](https://medium.com/@epiren/followers?source=post_page---post_author_info--a1ab9e6119fa---------------------------------------)\n\n· [713 following](https://medium.com/@epiren/following?source=post_page---post_author_info--a1ab9e6119fa---------------------------------------)\n\nI write about Love, Life, and Epidemics. Not necessarily in that order. In any case, I’ll inform you. And you’ll like it. Or not.\n\nFollow\n\n## Responses (9)\n\n![](https://miro.medium.com/v2/resize:fill:32:32/1*dmbNkD5D-u45r44go_cf0g.png)\n\nWrite a response\n\n[What are your thoughts?](https://medium.com/m/signin?operation=register&redirect=https%3A%2F%2Fmedium.com%2Fmicrobial-instincts%2Fthe-false-alarm-on-rubella-in-texas-was-a-warning-shot-and-we-should-pay-attention-a1ab9e6119fa&source=---post_responses--a1ab9e6119fa---------------------respond_sidebar------------------)\n\nCancel\n\nRespond\n\nSee all responses\n\n[Help](https://help.medium.com/hc/en-us?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Status](https://status.medium.com/?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[About](https://medium.com/about?autoplay=1&source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Careers](https://medium.com/jobs-at-medium/work-at-medium-959d1a85284e?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Press](mailto:pressinquiries@medium.com)\n\n[Blog](https://blog.medium.com/?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Privacy](https://policy.medium.com/medium-privacy-policy-f03bf92035c9?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Rules](https://policy.medium.com/medium-rules-30e5502c4eb4?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Terms](https://policy.medium.com/medium-terms-of-service-9db0094a1e0f?source=post_page-----a1ab9e6119fa---------------------------------------)\n\n[Text to speech](https://speechify.com/medium?source=post_page-----a1ab9e6119fa---------------------------------------)\n\nreCAPTCHA\n\nRecaptcha requires verification.\n\n[Privacy](https://www.google.com/intl/en/policies/privacy/) \\- [Terms](https://www.google.com/intl/en/policies/terms/)\n\nprotected by **reCAPTCHA**\n\n[Privacy](https://www.google.com/intl/en/policies/privacy/) \\- [Terms](https://www.google.com/intl/en/policies/terms/)",
    "query": "measles misdiagnosis rubella USA 2025"
  },
  {
    "snippet": "[Skip to main content](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#main-content)\n\n![](https://pmc.ncbi.nlm.nih.gov/static/img/icon-dot-gov.svg)\n\n**Official websites use .gov**\n\nA\n**.gov** website belongs to an official\ngovernment organization in the United States.\n\n\n![](https://pmc.ncbi.nlm.nih.gov/static/img/icon-https.svg)\n\n**Secure .gov websites use HTTPS**\n\nA **lock** (\nLock\nLocked padlock icon\n) or **https://** means you've safely\nconnected to the .gov website. Share sensitive\ninform...",
    "content": "[Skip to main content](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#main-content)\n\n![](https://pmc.ncbi.nlm.nih.gov/static/img/icon-dot-gov.svg)\n\n**Official websites use .gov**\n\nA\n**.gov** website belongs to an official\ngovernment organization in the United States.\n\n\n![](https://pmc.ncbi.nlm.nih.gov/static/img/icon-https.svg)\n\n**Secure .gov websites use HTTPS**\n\nA **lock** (\nLock\nLocked padlock icon\n) or **https://** means you've safely\nconnected to the .gov website. Share sensitive\ninformation only on official, secure websites.\n\n\n### Notice\n\nBecause of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit [cc.nih.gov](http://cc.nih.gov/). Updates regarding government operating status and resumption of normal operations can be found at [opm.gov](https://www.opm.gov/).\n\n[Home](https://pmc.ncbi.nlm.nih.gov/ \"Home\")\n\nSearch PMC Full-Text Archive\n\nSearch in PMC![Search](https://pmc.ncbi.nlm.nih.gov/static/img/usa-icons-bg/search--white.svg)\n\n- [Journal List](https://pmc.ncbi.nlm.nih.gov/journals/)\n- [User Guide](https://pmc.ncbi.nlm.nih.gov/about/userguide/)\n\n- [View on publisher site](https://doi.org/10.7759/cureus.88196) View on publisher site\n- [Download PDF](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/pdf/cureus-0017-00000088196.pdf) Download PDF\n- Add to Collections\n- Cite\n- Permalink\n\n\n\n\n## PERMALINK\n\n\n\nCopy\n\n\nAs a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,\nthe contents by NLM or the National Institutes of Health.\n\nLearn more:\n[PMC Disclaimer](https://pmc.ncbi.nlm.nih.gov/about/disclaimer/)\n\\|\n[PMC Copyright Notice](https://pmc.ncbi.nlm.nih.gov/about/copyright/)\n\n![Cureus logo](https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cureus.png)\n\nCureus\n\n. 2025 Jul 17;17(7):e88196. doi: [10.7759/cureus.88196](https://doi.org/10.7759/cureus.88196)\n\n# The 2025 United States Measles Crisis: When Vaccine Hesitancy Meets Reality\n\n[Adekunle F Adeoye](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adeoye%20AF%22%5BAuthor%5D)\n\n### Adekunle F Adeoye\n\n1\nPublic Health, Georgia State University, Atlanta, USA\n\nFind articles by [Adekunle F Adeoye](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adeoye%20AF%22%5BAuthor%5D)\n\n1,✉, [Daniel O Umoru](https://pubmed.ncbi.nlm.nih.gov/?term=%22Umoru%20DO%22%5BAuthor%5D)\n\n### Daniel O Umoru\n\n2\nPharmacy, National Hospital Abuja, Abuja, NGA\n\nFind articles by [Daniel O Umoru](https://pubmed.ncbi.nlm.nih.gov/?term=%22Umoru%20DO%22%5BAuthor%5D)\n\n2, [Ousainou O Gomez](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gomez%20OO%22%5BAuthor%5D)\n\n### Ousainou O Gomez\n\n3\nBiostatistics and Epidemiology, Georgia State University, Atlanta, USA\n\nFind articles by [Ousainou O Gomez](https://pubmed.ncbi.nlm.nih.gov/?term=%22Gomez%20OO%22%5BAuthor%5D)\n\n3, [Isreal A Onifade](https://pubmed.ncbi.nlm.nih.gov/?term=%22Onifade%20IA%22%5BAuthor%5D)\n\n### Isreal A Onifade\n\n4\nBiology, University of Albany, Albany, USA\n\nFind articles by [Isreal A Onifade](https://pubmed.ncbi.nlm.nih.gov/?term=%22Onifade%20IA%22%5BAuthor%5D)\n\n4, [Benjamin O Akangbe](https://pubmed.ncbi.nlm.nih.gov/?term=%22Akangbe%20BO%22%5BAuthor%5D)\n\n### Benjamin O Akangbe\n\n1\nPublic Health, Georgia State University, Atlanta, USA\n\nFind articles by [Benjamin O Akangbe](https://pubmed.ncbi.nlm.nih.gov/?term=%22Akangbe%20BO%22%5BAuthor%5D)\n\n1, [Ubalaeze S Elechi](https://pubmed.ncbi.nlm.nih.gov/?term=%22Elechi%20US%22%5BAuthor%5D)\n\n### Ubalaeze S Elechi\n\n5\nRadiology, Lifechart Medical Diagnostic Services, Enugu, NGA\n\n6\nDigital Health, University of Nigeria, Enugu, NGA\n\nFind articles by [Ubalaeze S Elechi](https://pubmed.ncbi.nlm.nih.gov/?term=%22Elechi%20US%22%5BAuthor%5D)\n\n5,6, [Vincent U Barrah](https://pubmed.ncbi.nlm.nih.gov/?term=%22Barrah%20VU%22%5BAuthor%5D)\n\n### Vincent U Barrah\n\n7\nPublic Health, Chicago State University, Chicago, USA\n\nFind articles by [Vincent U Barrah](https://pubmed.ncbi.nlm.nih.gov/?term=%22Barrah%20VU%22%5BAuthor%5D)\n\n7\n\nEditors: Alexander Muacevic, John R Adler\n\n- Author information\n- Article notes\n- Copyright and License information\n\n1\nPublic Health, Georgia State University, Atlanta, USA\n\n2\nPharmacy, National Hospital Abuja, Abuja, NGA\n\n3\nBiostatistics and Epidemiology, Georgia State University, Atlanta, USA\n\n4\nBiology, University of Albany, Albany, USA\n\n5\nRadiology, Lifechart Medical Diagnostic Services, Enugu, NGA\n\n6\nDigital Health, University of Nigeria, Enugu, NGA\n\n7\nPublic Health, Chicago State University, Chicago, USA\n\n✉\n\nAdekunle F. Adeoye aadeoye2@gsu.edu\n\n✉\n\nCorresponding author.\n\nAccepted 2025 Jul 17; Collection date 2025 Jul.\n\nCopyright © 2025, Adeoye et al.\n\nThis is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.\n\n[PMC Copyright notice](https://pmc.ncbi.nlm.nih.gov/about/copyright/)\n\nPMCID: PMC12357784  PMID: [40827145](https://pubmed.ncbi.nlm.nih.gov/40827145/)\n\n## Abstract\n\nThis narrative review examines how declining vaccine uptake and growing vaccine hesitancy created pockets of susceptibility that enabled the outbreak and analyzes the epidemiological features and public health response. Key drivers of vaccine hesitancy (misinformation about vaccine safety, philosophical and religious exemptions, and pandemic-related disruptions) are discussed, along with the demographic patterns of under-vaccination in the U.S. Comparisons are drawn to notable measles outbreaks in Samoa (2019) and the United Kingdom (2018) to highlight common themes of insufficient immunity leading to severe outcomes. The review evaluates what aspects of the public health response were effective, including emergency vaccination campaigns, community engagement, and interagency coordination, and what challenges and failures impeded control, such as resource limitations and delayed counter-misinformation efforts. The economic impact of the outbreak is also considered, with containment efforts costing millions of dollars. We summarize the lessons learned about the importance of maintaining high vaccination coverage and suggest policy implications, which include stricter immunization requirements, proactive education to combat misinformation, and strengthening immunization infrastructure. Finally, future directions and recommendations are presented to prevent measles from regaining a foothold, emphasizing that sustained commitment to vaccination and public trust is critical to averting similar crises.\n\n**Keywords:** measles, public health coverage, united states of america, vaccination coverage, vaccine hesitancy\n\n## Introduction and background\n\nMeasles, once a ubiquitous childhood infection in the U.S., was declared eliminated nationally in 2000 after decades of widespread vaccination and vigilant surveillance \\[ [1](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF1)\\]. Yet elimination never guaranteed permanence. During the 2010s, an erosion of public confidence in vaccines, amplified by online misinformation, chipped away at the herd immunity that had suppressed endemic transmission \\[ [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF2)\\]. Concerningly, kindergarten coverage with the recommended two doses of the measles-mumps-rubella (MMR) vaccine fell from 95.2% in the 2019-2020 school year to 92.7% in 2023-2024, leaving an estimated 280,000 children susceptible \\[ [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF3)\\].\n\nThe consequences of those immunity gaps became starkly apparent in early 2025. On 30 May 2025, the Centers for Disease Control and Prevention (CDC) reported 1,088 confirmed measles cases across 33 jurisdictions, including the first measles-related deaths recorded in the country since 2015 \\[ [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF4)\\]. More than 90% of patients were unvaccinated or had unknown vaccination status, and nearly all cases were epidemiologically linked to undervaccinated communities in Texas, New Mexico, and Oklahoma. Air travel and domestic tourism quickly distributed the virus to additional states, illustrating how a single imported case can ignite nationwide spread when local protection is uneven.\n\nAlthough the absolute numbers remain modest compared with the pre-vaccine era, the 2025 outbreak represents the largest U.S. measles crisis in a decade and a critical stress test of the nation’s vaccine policy architecture. It also mirrors recent international setbacks, notably the 2018 United Kingdom resurgence and the 2019 Samoa epidemic, underscoring that measles control is precarious wherever vaccination falters.\n\nIn this narrative review, we synthesize current evidence to elucidate (1) the historical and epidemiologic context of the 2025 U.S. outbreak, (2) the socio-behavioral and policy drivers of vaccine hesitancy that primed the crisis, (3) the strengths and weaknesses of the public health response, (4) the human and economic costs incurred, and (5) the lessons and forward-looking strategies required to restore and sustain measles elimination. By integrating national data with insights from global comparators, we aim to furnish clinicians, policymakers, and public health practitioners with a comprehensive blueprint for preventing measles from regaining a foothold in the U.S.\n\n## Review\n\nMethods\n\nFor this narrative review, we conducted a comprehensive literature search of PubMed, Google Scholar, and official health organization websites (CDC, WHO) to identify sources on measles outbreaks, vaccination coverage, vaccine hesitancy, and public health responses published between 2010 and 2025. Sources were eligible if they (i) contained primary or secondary data on measles epidemiology, vaccination coverage, or hesitancy; (ii) were published in English during 2010-2025; and (iii) offered a verifiable DOI or permanent URL. Editorials without data, conference abstracts, and duplicate preprints were excluded. Search terms included combinations of “measles,” “outbreak,” “vaccine hesitancy,” “measles 2025,” “vaccination coverage,” “measles mortality,” and “measles elimination.” We prioritized peer-reviewed articles (epidemiological studies, reviews, commentaries) and authoritative reports (e.g., Morbidity and Mortality Weekly Report (MMWR) briefs, WHO updates), with particular focus on data from the 2025 U.S. outbreak and comparator events such as the 2019 Samoa epidemic and the 2018 measles resurgence in Europe. Outbreak case counts and vaccination-coverage figures were cross-checked against the CDC and WHO databases for accuracy. All U.S. 2025 figures reflect data current as of 30 May 2025.\n\nHistorical perspective and outbreak epidemiology\n\nMeasles elimination in the U.S. was achieved in 2000 through decades of high vaccine coverage and aggressive public health campaigns \\[ [5](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF5)\\]. In the years immediately after, only a handful of cases occurred annually, typically in travelers or their close contacts. However, by the 2010s, declining vaccination in certain communities led to a series of outbreaks. For example, in 2017, a measles outbreak in Minnesota’s Somali-American community, where unfounded fears about MMR causing autism had spread, resulted in 75 cases \\[ [6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF6)\\]. These incidents were a prelude to a larger resurgence in 2019, when the U.S. recorded 1,282 cases, the most since 1992 \\[ [7](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF7)\\]. That year, the vast majority of cases were confined to under-immunized enclaves, including a prolonged outbreak of 934 cases in Orthodox Jewish neighborhoods in New York that nearly cost the country its elimination status. Although no measles deaths occurred in 2019, the outbreaks were a wake-up call that highlighted growing vaccine complacency.\n\nThis American pattern mirrored global trends. Europe saw measles cases surge in 2018-2019, and the United Kingdom lost its measles-free status after a protracted outbreak (991 cases in 2018) reestablished endemic transmission \\[ [8](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF8)\\]. In late 2019, Samoa experienced a devastating measles epidemic, with over 5,700 cases and 83 deaths, after national MMR coverage fell to around 30% \\[ [9](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF9)\\]. These examples demonstrate that if vaccination rates decline, measles can resurface and cause significant harm.\n\nOutbreak epidemiology\n\nThe 2025 U.S. measles outbreak began in early January, seeded by an infected traveler in a close-knit, undervaccinated community in West Texas. From there, the virus spread across at least three states (Texas, New Mexico, and Oklahoma) among populations with historically low MMR uptake. By 17 April 2025, the CDC had reported 800 cases nationally, already the second-highest annual total in 25 years, and it was noted that 82% were linked to the outbreak in those three states \\[ [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF10)\\]. Despite control efforts, the case count continued to rise; as of 29 May 2025, a total of 1,088 measles cases had been confirmed across 33 states \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\]. Fourteen distinct outbreaks (defined as three or more linked cases) were identified in 2025, though the majority of all cases were associated with the large Texas-centered outbreak. Figure [1](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#FIG1) depicts the weekly accumulation of cases from 6 January through 30 May 2025, illustrating the rapid March-to-April growth phase and subsequent deceleration.\n\n### Figure 1. Weekly Cumulative Measles Cases, United States, 2025.\n\n[![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b052/12357784/acc55e585b88/cureus-0017-00000088196-i01.jpg)](https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=12357784_cureus-0017-00000088196-i01.jpg)\n\n[Open in a new tab](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/figure/FIG1/)\n\nWeekly cumulative measles cases in the United States, 1 January-30 May 2025. The outbreak begins with an imported index case in Texas during the first week of January, accelerates sharply through March, peaks in mid-April, and slows after nationwide response measures were intensified in mid-March (gray band).\n\nImage credit: Ubalaeze Solomon Elechi, created with OpenAI’s GPT-4 and DALL-E tools\n\nThe epidemiological profile of the outbreak highlights the consequences of immunity gaps. More than 90% of patients were unvaccinated or had unknown vaccination status (per CDC reports), and many belonged to communities that had resisted routine immunizations. Cases spanned all age groups, but young children were heavily affected: roughly one-third of cases were in children under five (including many infants too young to be vaccinated), another third in school-aged children, and the remainder in adults. About 1 in 10 patients required hospitalization for measles complications or isolation. Most tragically, three measles-related deaths occurred (two children and one immunocompromised adult), the first U.S. measles fatalities in over 20 years \\[ [12](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF12)\\]. Genomic analyses confirmed that the outbreaks stemmed from imported virus strains, not a new endemic variant \\[ [13](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF13)\\]. Notably, travel played a role in amplifying the spread: for instance, several cases in Colorado and Illinois were traced to exposures during domestic airline flights and at tourist destinations \\[ [14](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF14)\\]. These scenarios illustrated how quickly measles can hop between susceptible pockets. As illustrated in Figure [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#FIG2), sustained measles activity in 2025 global hotspots, particularly parts of Europe, Southeast Asia, and sub-Saharan Africa, generated multiple air-travel corridors into major U.S. airports, ultimately funneling cases into the undervaccinated Texas-New Mexico-Oklahoma cluster that seeded the domestic outbreak. Conversely, areas with high vaccination coverage largely escaped secondary transmission, demonstrating the protective value of herd immunity where it remained intact.\n\n### Figure 2. International Measles Transmission Pattern.\n\n[![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b052/12357784/b7a1c69aa296/cureus-0017-00000088196-i02.jpg)](https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=12357784_cureus-0017-00000088196-i02.jpg)\n\n[Open in a new tab](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/figure/FIG2/)\n\nConceptual illustration of measles spread through international air travel. In 2025, imported measles cases (infected travelers arriving in the U.S.) ignited outbreaks in undervaccinated communities. Global travel has linked measles outbreaks across continents, underscoring that high vaccination coverage is needed everywhere to prevent cross-border spread.\n\nImage credit: Ubalaeze Solomon Elechi, created with OpenAI’s GPT-4 and DALL-E tools\n\nComparative Analysis: Affected Versus Unaffected States\n\nAs of 30 May 2025, the three core outbreak states (Texas, New Mexico, and Oklahoma) recorded a mean incidence of 7.4 cases per million residents, whereas the remaining 47 jurisdictions averaged 0.06 cases per million, a 120-fold difference \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\]. States in the lowest kindergarten MMR-coverage quartile (≤ 92%) accounted for 87% of all U.S. cases, while no state with ≥ 96% coverage reported more than five cases \\[ [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF3)\\]. This inverse relationship between coverage and incidence mirrors modeling work showing that every percentage-point drop in two-dose coverage increases outbreak probability by roughly 14% \\[ [15](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF15)\\].\n\nGranular Demographic Breakdown\n\nThe U.S. 2025 cases had a demographic profile of 1,088 individuals. Among line-listed patients, 34% were children under five years of age, 33% were school-aged (5-17 years), and 28% were adults ≥ 18 years; the remaining 5% had age unreported \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\]. Hospitalization was required for 11% of cases overall, rising to 18% in infants < 12 months. Vaccination status was known for 1,012 patients: 86% were unvaccinated, 7% had received only one MMR dose, and 7% were fully vaccinated, yielding an estimated two-dose effectiveness of 97% against confirmed disease. Sex distribution was balanced (51% male). Racial/ethnic data, available for 62% of cases, showed over-representation of Hispanic/Latino children in the Texas and New Mexico clusters, while non-Hispanic White children predominated in the Oklahoma and Colorado clusters \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\].\n\nVaccine hesitancy: drivers and demographics\n\nMeasles outbreaks in the 21st century have been overwhelmingly linked to clusters of unvaccinated individuals, raising the question: Why are people forgoing a readily available, life-saving vaccine? The drivers of vaccine hesitancy are multifaceted. Foremost is misinformation about vaccine safety, notably the debunked claim linking the MMR vaccine to autism, originally propagated by a fraudulent study in 1998 \\[ [16](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF16)\\]. Fear of autism remains a leading reason cited by parents who refuse MMR for their children. Other parental concerns include perceived risks of vaccine side effects, the belief that “natural” immunity is healthier, and general distrust of pharmaceutical companies or government health agencies. Social media and online echo chambers have amplified vaccine misinformation, allowing anti-vaccine activists to sow doubt about the MMR vaccine’s safety despite an overwhelming scientific consensus of its safety and efficacy. The result has been a measurable decline in public confidence in childhood vaccines in some communities. The WHO identified vaccine hesitancy as one of the top 10 threats to global health in 2019 \\[ [2](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF2)\\], acknowledging that complacency and misinformation were undermining decades of progress. In the U.S., the COVID-19 pandemic may have further fueled hesitancy; not only did routine pediatric vaccination rates dip during pandemic lockdowns, but polarized debates around COVID-19 vaccines spilled over to routine immunizations, reinforcing doubts among some groups \\[ [17](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF17)\\].\n\nLegacy of the MMR-Autism Myth\n\nPersistent concern that the MMR vaccine causes autism remains the single most frequently cited reason for MMR refusal in U.S. parent surveys \\[ [18](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF18)\\]. Evidence refuting this link is unequivocal: a 2014 population-based meta-analysis of over 1.2 million children found no association between MMR exposure and autism spectrum disorder (ASD) \\[ [19](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF19)\\]. A nationwide Danish cohort study covering 657,461 births likewise reported a null association (adjusted hazard ratio = 0.93; 95% confidence interval (CI): 0.85-1.02) \\[ [20](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF20)\\]. Most recently, an updated U.K. matched-cohort analysis reaffirmed that ASD incidence is identical in vaccinated and unvaccinated children \\[ [21](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF21)\\]. Despite this consensus, online recirculation of the discredited 1998 Wakefield paper continues to seed hesitancy within some communities, indicating the importance of proactive, evidence-based communication strategies.\n\nDemographics\n\nHesitancy is not uniform across the population; it clusters in specific demographics and communities. Paradoxically, areas with higher socioeconomic status and education levels have at times harbored more vaccine-refusing parents. For example, communities in California and Colorado, where “natural lifestyle” movements flourish, saw MMR vaccination rates fall well below 90% before policy changes. In the 2023-2024 school year, the national average MMR coverage for kindergarteners was 92.7%, but this average masks geographic pockets of much lower coverage \\[ [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF3)\\]. Fourteen U.S. states reported that over 5% of their kindergarten students had non-medical vaccine exemptions in 2023-2024, with the national exemption rate rising to 3.3% \\[ [22](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF22)\\]. These exemptions, often due to personal or religious belief waivers, tend to concentrate in certain schools and communities, creating pockets of susceptibility. Religious or cultural beliefs also play a role: insular religious communities (such as the Amish, some Orthodox Jewish groups, and certain fundamentalist churches) have experienced measles outbreaks after members declined vaccines for faith-related reasons \\[ [23](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF23)\\]. Minority communities can face unique challenges; for instance, Somali-American families in Minnesota were targeted by anti-vaccine misinformation about autism, leading to a dramatic drop in MMR uptake and a subsequent measles outbreak in 2017 within that community \\[ [23](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF23)\\]. Additionally, structural barriers and healthcare access inequalities mean some children miss vaccinations not by choice but due to healthcare system gaps, although the Vaccines for Children program and public health clinics aim to minimize this in the U.S.\n\nThe demographics of the 2025 measles outbreak reflect these hesitancy patterns. Several West Texas counties at the center of the 2025 outbreak have carried kindergarten two-dose MMR coverage well below the 90% threshold for multiple consecutive years: Briscoe County, TX, 80.0%; Childress County, TX, 70.5%; and Dawson County, TX, 88.1%, compared with the 2023-2024 national average of 92.7% \\[ [24](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF24), [25](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF25)\\]. CDC line-list data show that through 17 April 2025, 69% of U.S. measles cases occurred in persons < 20 years of age (38% aged 5-19 years and 31% aged < 5 years), and over 90% of all patients were either unvaccinated or of unknown vaccination status \\[ [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF10), [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\], patterns consistent with pockets of routine-immunization refusal in the affected communities. Meanwhile, several adult measles cases in the 2025 outbreak were individuals who had never been vaccinated due to similar beliefs or who missed childhood vaccination and lacked awareness of the need. Ultimately, the outbreak was driven by immunity gaps rather than any change in the virus or the vaccine. Vaccine hesitancy, fueled by fear, misinformation, and sociocultural dynamics, supplied the tinder, and a single imported case ignited an epidemic in these unprotected communities.\n\nPublic health response and economic impact: what worked, what failed\n\nContaining the 2025 outbreaks required a swift and coordinated public health response. Local, state, and federal agencies implemented classic measures: prompt isolation of cases, contact tracing, and targeted vaccination of susceptible contacts and communities \\[ [26](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF26)\\]. Health departments in Texas and neighboring states held emergency immunization clinics and, in affected counties, even recommended an early MMR dose for infants 6-11 months old \\[ [27](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF27)\\]. Schools in outbreak areas excluded unvaccinated students during the incubation period, and public health officials issued travel advisories and alerts to clinicians. These efforts, alongside extensive community outreach, eventually curbed the spread by early summer 2025 \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\]. As summarized in Table [1](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#TAB1), the 2025 U.S. outbreak’s scale was comparable to recent high-profile resurgences in Samoa (2019) and the United Kingdom (2018), underscoring how gaps in coverage translate into costly public-health responses.\n\n### Table 1. Key Measles Outbreaks in Recent Years (Selected Examples).\n\nNote: Immunization coverage refers to the estimated national or subnational uptake of the first and/or second dose of MMR vaccine prior to each outbreak. Data were compiled from the CDC and WHO reports. \"Pockets of low coverage\" denote geographic or demographic subgroups with significantly lower-than-average vaccine uptake, which contributed to outbreak vulnerability.\n\nMMR: measles, mumps, and rubella vaccine; WHO: World Health Organization; U.S.: United States\n\n|     |     |     |     |     |\n| --- | --- | --- | --- | --- |\n| Location (Year) | Cases | Deaths | Immunization Coverage (Pre-outbreak) | Notable Characteristics |\n| United States (2019) | 1,282 | 0 | ~94% nationwide; pockets of low coverage (some communities < 80%) | Largest U.S. measles outbreak since 1992; concentrated in under-vaccinated Orthodox Jewish communities (~75% of cases); elimination status narrowly preserved \\[ [7](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF7)\\]. |\n| United States (2025) | 1,088 | 3 | 92.7% nationwide; local pockets < 70% | Worst U.S. outbreak since 2019 (ongoing); ~90% of cases in unvaccinated persons; includes a major outbreak in West Texas/New Mexico (82% of 2025 cases) \\[ [11](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF11)\\]. |\n| United Kingdom (2018) | 991 | 3 | ~95% (first dose), ~87% (second dose) at school entry | Lost WHO “measles-free” status after a prolonged outbreak reestablished endemic transmission; measles cases doubled from 2017 to 2018, with several fatalities in unvaccinated children \\[ [8](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF8)\\]. |\n| Samoa (2019) | 5,707 | 83 | ~30% (estimated MMR coverage before outbreak) | Nationwide epidemic following a dramatic drop in vaccination; > 80% of deaths in children < 5 years; state of emergency declared with mass vaccination campaign to raise coverage \\[ [9](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF9)\\]. |\n\n[Open in a new tab](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/table/TAB1/)\n\nCertain response strategies clearly worked. Rapid case identification through vigilant surveillance and laboratory testing allowed timely interventions. Interagency communication (fortified by pandemic-era coordination frameworks) facilitated resource sharing, and community leaders were engaged to promote vaccination in hesitant populations \\[ [26](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF26)\\]. The fact that measles did not become endemic beyond the initial clusters is a testament to these control measures. However, the outbreak also exposed gaps. Years of inadequate investment in vaccine education meant that by the time officials mobilized messaging in 2025, misinformation was deeply entrenched in the hardest-hit communities \\[ [28](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF28)\\]. Understaffed local health departments struggled with the surge in contact tracing and immunization workloads, reflecting a broader disinvestment in public health infrastructure. Jurisdictional complexities (for example, coordinating quarantine across state lines) at times hampered the speed of response. On 7 March 2025, the CDC issued Health Alert Network Advisory #00522 instructing jurisdictions to isolate suspected cases, trace contacts, and administer post-exposure MMR within 72 hours or immune globulin within six days \\[ [26](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF26), [29](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF29)\\]. Within a week, the Texas Department of State Health Services (DSHS) circulated the same protocol to county health departments \\[ [30](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF30)\\]. Yet rural West Texas counties reported that vaccine stockpiles were depleted and that only one or two immunization nurses were available for surge duty, producing contact-tracing backlogs of 48-60 hours \\[ [31](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF31), [32](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF32)\\]. The 2022 NACCHO Profile Survey had already found that 51% of U.S. local health departments lacked sufficient staff to manage vaccine-preventable disease (VPD) surges \\[ [33](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF33)\\], a gap echoed in Texas after-action reviews. Meanwhile, the CDC’s advisory recommended furlough of exposed but non-immune healthcare workers; several rural hospitals complied yet could not backfill shifts, forcing diversion of febrile-rash patients to distant facilities \\[ [34](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF34)\\]. These examples illustrate how robust federal guidance can be blunted when county-level workforce and vaccine reserves are inadequate \\[ [28](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF28)\\].\n\nThe economic impact of the outbreak was substantial. Measles containment is labor-intensive and costly: each case requires investigation and follow-up of many contacts, and quarantines and public information campaigns carry significant costs. A recent analysis of a 2019 measles outbreak in Washington State estimated an average cost of about $47,000 per measles case (including public health response and productivity losses) \\[ [35](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF35)\\]. Using that figure, more than 1,000 cases in 2025 imposed tens of millions of dollars in societal costs. Most of this expense fell on public health agencies that diverted personnel and resources to the outbreak, as well as on hospitals that treated severe cases. These costs far exceed the investments that would have been needed to maintain high vaccination coverage in the first place, a stark economic argument for prevention \\[ [36](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF36)\\].\n\nVulnerable populations and health disparities\n\nCertain groups suffered disproportionately during the measles resurgence. Infants too young to be vaccinated (under 12 months) were at extreme risk; many of the 2025 cases occurred in babies less than a year old, including one of the fatal cases \\[ [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF10)\\]. Children under five years of age in general are highly vulnerable to measles complications like pneumonia and encephalitis; historically, this age group accounts for the majority of measles deaths worldwide \\[ [37](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF37)\\]. In Samoa’s 2019 outbreak, 87% of measles fatalities were in children under five. The 2025 U.S. outbreak reaffirmed this pattern, as young children made up a large share of hospitalizations and the two pediatric deaths.\n\nBeyond age, immunocompromised individuals are another vulnerable population. People who cannot receive live vaccines due to conditions such as leukemia or immunosuppressive therapy rely on herd immunity for protection \\[ [38](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF38)\\]. The death of an adult cancer patient in the 2025 outbreak (who contracted measles from his community) underscores that even a single measles case in the wrong setting can be devastating. Pregnant women are also at elevated risk of severe measles and adverse pregnancy outcomes, although fortunately, no pregnant patients died in 2025 \\[ [39](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF39)\\].\n\nMeasles outbreaks tend to exploit social and economic disparities. Underserved communities with limited healthcare access may have lower vaccination rates not out of intent, but because of practical barriers. Parent interviews in the CDC’s National Immunization Survey identified lack of transportation, inconvenient clinic hours, and childcare costs as common obstacles to keeping vaccine appointments \\[ [40](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF40)\\]. At the same time, several of the worst recent outbreaks (in the U.S. and abroad) have occurred in relatively insular communities (defined by religious or cultural ties) that resist vaccination, regardless of socioeconomic status. Vulnerability to measles is shaped not only by socioeconomic access but also by beliefs and information: California data show personal-belief exemptions cluster in affluent, highly educated communities \\[ [6](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF6), [41](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF41)\\], while the 2017 Somali-American outbreak in Minnesota stemmed from autism-related vaccine fears despite free clinic availability. In 2025, some rural counties with healthcare provider shortages experienced delayed diagnoses, which allowed wider spread \\[ [42](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF42)\\]. Language and cultural barriers further hampered warning efforts in certain immigrant communities. Addressing these issues requires culturally competent engagement well before outbreaks occur. Ultimately, the presence of measles anywhere reveals which populations have been left behind, whether due to marginalization or misinformation, and those gaps must be closed to protect everyone.\n\nThe persistence of “zero-dose” children, those who have not received even a first dose of any routine vaccine, has become a key global indicator of immunization system fragility \\[ [43](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF43)\\]. The undervaccinated pockets that fueled the 2025 U.S. outbreak function much like zero-dose clusters in low- and middle-income countries, suggesting that domestic dashboards could adopt the same metric to flag communities where measles is most likely to resurge.\n\nLessons learned and policy implications\n\nThe 2025 experience has crystallized several lessons for policymakers and public health practitioners. Foremost, maintaining high vaccination coverage is essential. The reemergence of measles in the U.S. vividly demonstrated that even small declines in community immunity can have far-reaching consequences. Therefore, proactive measures to counter vaccine hesitancy should be a permanent fixture of public health work. Such action includes continuous public education that adapts to evolving misinformation, as well as readily accessible vaccination services.\n\nOne policy implication is the reconsideration of vaccine exemption policies. States with lenient non-medical exemption (NME) rules observed a higher concentration of unvaccinated children \\[ [44](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF44)\\], and this outbreak disproportionately affected those clusters. Stricter requirements (for example, only permitting medical exemptions, as California and some other states have done) could be expanded to more jurisdictions. At minimum, simplifying the process for families to vaccinate could help raise immunization rates \\[ [45](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF45)\\]. Schools and daycare centers are critical enforcement points; ensuring they have the mandate and resources to verify student vaccinations and exclude unvaccinated individuals during outbreaks is key.\n\nAnother lesson is the importance of engaging communities and building trust long before health emergencies arise. Combatting misinformation isn’t just about debunking myths in the media; it requires on-the-ground relationships. Local health departments might establish dedicated outreach teams to work with communities known to have lower vaccination rates, partnering with local leaders, clergy, and healthcare providers to deliver consistent pro-vaccine messages \\[ [46](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF46)\\]. Listening and dialogue are as important as messaging in this effort; people’s concerns must be heard and addressed respectfully to rebuild trust. The outbreak showed that trying to change minds in the midst of a crisis is extremely difficult; the groundwork must be laid in advance.\n\nThe outbreak also strengthens the argument for investing in public health infrastructure. The relative containment of measles (it did not become endemic nationwide) was due in part to the rapid mobilization of public health teams. Yet the strain on those teams was apparent: at the height of the response, Texas could field only 2,800 contact tracers, after 400 had been reassigned, against the governor’s target of 4,000 and well below independent estimates of 9,000 to 20,000 needed for statewide control \\[ [47](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF47)\\]. Policymakers should see these findings as evidence that funding stable epidemiology and immunization programs (not just emergency surge funding) is an investment that pays off. Modernizing immunization information systems to better identify pockets of under-vaccination can enable targeted interventions in the future. For example, predictive modeling studies suggest that without improvements, the U.S. could see measles regaining a foothold within a few decades. One recent model estimated that a sustained 10% decline in MMR coverage could lead to over 11 million measles cases in the U.S. over 25 years \\[ [48](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF48)\\]. Such scenarios underscore the urgency of taking preventive actions now.\n\nFinally, there is a global dimension to these lessons. Measles anywhere is a threat everywhere. The U.S. will remain at risk of importation as long as measles circulates globally, so supporting international vaccination efforts (through the WHO, the United Nations International Children's Emergency Fund (UNICEF), and other initiatives) aligns with national self-interest \\[ [37](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF37)\\]. The Samoa and UK experiences show that even relatively small populations can generate large outbreaks that reverberate internationally. Thus, recommitting to the global measles elimination agenda is part of the solution; this includes sharing best practices, data, and resources to bolster measles control in every region.\n\nThe 2025 crisis taught us that complacency is dangerous. However, it has also presented an opportunity and acted as a catalyst to fortify policies and programs, ensuring that a disease such as measles doesn't surprise us in the future.\n\nFuture directions and recommendations\n\nThe priority should and must be to translate these lessons into concrete action \\[ [49](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF49)\\]. This review’s findings support several recommendations. First, immunization policy should be updated to ensure more uniform coverage, for instance, by narrowing exemption allowances and considering requirements for documentation of immunity in settings like colleges or healthcare employment \\[ [38](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF38), [45](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF45)\\]. Second, we recommend enhanced investment in vaccine education and outreach, taking advantage of social media and community networks to spread accurate information and counter myths \\[ [50](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF50)\\]. Programs that train local trusted figures (teachers, religious leaders, etc.) to advocate for vaccination could be expanded \\[ [49](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF49)\\]. Third, innovative solutions to improve vaccine uptake should be pursued: for example, research into needle-free vaccine delivery (such as microneedle patches for measles) could reduce barriers and fear, and integrating vaccination reminders into electronic health records and pharmacy systems could increase convenience \\[ [51](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF51)\\].\n\nIt is also advisable to incorporate checks of measles vaccination status into routine healthcare and public health activities. For instance, pediatricians should consistently review and catch up on immunizations at every visit, and public health programs might organize periodic “vaccination days” in communities with low coverage, offering free MMR shots with minimal red tape.\n\nOn a national preparedness level, establishing rapid response teams specifically for VPD outbreaks could improve reaction time. These teams could be pre-trained and deployed when clusters of measles (or similar diseases) are detected, much like disaster response units.\n\nImplementation should be audited with clear metrics. Nationally, the CDC already tracks two-dose MMR coverage through SchoolVaxView; the Healthy People 2030 benchmark is ≥ 95% in every state \\[ [3](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF3), [52](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF52)\\]. Jurisdictions could add the “7-1-7” timeliness target, detect a cluster within seven days, begin investigation within one day, and complete initial control within seven days as a rapid-response scorecard for VPD outbreaks \\[ [53](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF53)\\]. Health departments could use county-level dashboards that publish real-time kindergarten MMR and exemption percentages from immunization-information-system (IIS) feeds to trigger outreach whenever coverage drops below the 92% herd-immunity threshold.\n\nPolicy experience shows that narrowing NMEs quickly boosts coverage. After California abolished personal-belief exemptions, kindergarten MMR coverage increased from 92.8% to 95.1% in two years \\[ [45](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF45)\\], while Maine’s 2019 repeal of NMEs produced a 4-point gain, with coverage reaching 97% by 2024-2025 \\[ [54](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF54)\\].\n\nInternationally, the U.S. can lead by example by re-achieving measles elimination and maintaining it \\[ [49](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF49)\\]. This means stopping current outbreaks and building a resilient system that quickly addresses any future importation. It also means continuing to support global measles control, such as contributing to global vaccine stockpiles and outbreak response funds and assisting other countries in strengthening their immunization programs.\n\nIn the end, the direction is clear: prevent, prevent, prevent. The tools to avoid measles outbreaks exist, and the 2025 crisis has reinforced that we must use them proactively. By doing so, we protect not only our communities but also contribute to the global fight against a virus that no longer needs to cause suffering in the 21st century \\[ [55](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/#REF55)\\].\n\n## Conclusions\n\nThe 2025 U.S. measles outbreak is a sobering reminder that public health victories are never permanent. When population immunity slips, even slightly, vaccine-preventable diseases regain a foothold. Yet the episode also proved that rapid, well-coordinated public health action can still break chains of transmission before measles becomes endemic again. The task ahead is to convert the lessons learned into stronger policies, sustained outreach, and renewed trust in vaccination so we do not repeat this cycle.\n\nParents’ concerns do not end with disproven autism myths; many remain uneasy about the common, generally mild side effects that follow routine immunization. Addressing those concerns openly and consistently, making side effect profiles part of every informed-consent conversation, has been shown to build confidence rather than erode it. In the future, new methods for administering vaccines, such as microneedle patches or inhaled powders that don't require refrigeration, could make it easier to get vaccinated without needles and help reach people in remote areas. If these methods prove effective, they could help reduce fear and increase vaccination rates. Measles is fully preventable, and the tools to prevent it already exist. It is our collective responsibility to ensure the effective and equitable use of these tools. By doing so, we can turn the setback of 2025 into renewed momentum toward durable measles elimination, protecting today’s children and generations yet to come.\n\n## Acknowledgments\n\nThe article's figure preparation was assisted by OpenAI’s GPT-4 and DALL-E tools under the direct supervision of the authors.\n\n## Disclosures\n\n**Conflicts of interest:** In compliance with the ICMJE uniform disclosure form, all authors declare the following:\n\n**Payment/services info:** All authors have declared that no financial support was received from any organization for the submitted work.\n\n**Financial relationships:** All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.\n\n**Other relationships:** All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.\n\n## Author Contributions\n\n**Concept and design:**  Adekunle F. Adeoye, Daniel O. Umoru, Ousainou O. Gomez, Isreal A. Onifade, Vincent U. Barrah\n\n**Acquisition, analysis, or interpretation of data:**  Adekunle F. Adeoye, Benjamin O. Akangbe, Ubalaeze S. Elechi\n\n**Drafting of the manuscript:**  Adekunle F. Adeoye, Isreal A. Onifade, Ubalaeze S. Elechi\n\n**Critical review of the manuscript for important intellectual content:**  Adekunle F. Adeoye, Daniel O. Umoru, Ousainou O. Gomez, Benjamin O. Akangbe, Vincent U. Barrah\n\n**Supervision:**  Adekunle F. Adeoye, Ubalaeze S. Elechi, Vincent U. Barrah\n\n## References\n\n- 1.Measles - United States, 2000. \\[\\\nJun;\\\n2025\\\n\\]. 2002\\. [https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a2.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a2.htm). [https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a2.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5106a2.htm) \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/11898926/)\\]\n- 2.Ten threats to global health in 2019. \\[\\\nJun;\\\n2025\\\n\\]. 2019\\. [https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019](https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019) [https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019](https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019)\n- 3.Coverage with selected vaccines and exemption rates among children in kindergarten - United States, 2023-24 school year. Seither R, Yusuf OB, Dramann D, et al. MMWR Morb Mortal Wkly Rep. 2024;73:925–932. doi: 10.15585/mmwr.mm7341a3. \\[ [DOI](https://doi.org/10.15585/mmwr.mm7341a3)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC11486350/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/39418212/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=Coverage%20with%20selected%20vaccines%20and%20exemption%20rates%20among%20children%20in%20kindergarten%20-%20United%20States,%202023-24%20school%20year&volume=73&publication_year=2024&pages=925-932&pmid=39418212&doi=10.15585/mmwr.mm7341a3&)\\]\n- 4.Sriparna Roy. Measles cases in Texas rise by nine to 738, state health department says. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.reuters.com/business/healthcare-pharmaceuticals/measles-cases-texas-rise-by-nine-738-state-health-department-says-2025-05-30/](https://www.reuters.com/business/healthcare-pharmaceuticals/measles-cases-texas-rise-by-nine-738-state-health-department-says-2025-05-30/) [https://www.reuters.com/business/healthcare-pharmaceuticals/measles-cases-texas-rise-by-nine-738-state-health-department-says-2025-05-30/](https://www.reuters.com/business/healthcare-pharmaceuticals/measles-cases-texas-rise-by-nine-738-state-health-department-says-2025-05-30/)\n- 5.History of measles. \\[\\\nJun;\\\n2025\\\n\\]. 2024\\. [https://www.cdc.gov/measles/about/history.html](https://www.cdc.gov/measles/about/history.html) [https://www.cdc.gov/measles/about/history.html](https://www.cdc.gov/measles/about/history.html)\n- 6.Measles outbreak - Minnesota April-May 2017. Hall V, Banerjee E, Kenyon C, et al. MMWR Morb Mortal Wkly Rep. 2017;66:713–717. doi: 10.15585/mmwr.mm6627a1. \\[ [DOI](https://doi.org/10.15585/mmwr.mm6627a1)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC5687591/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/28704350/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=Measles%20outbreak%20-%20Minnesota%20April-May%202017&volume=66&publication_year=2017&pages=713-717&pmid=28704350&doi=10.15585/mmwr.mm6627a1&)\\]\n- 7.National update on measles cases and outbreaks - United States, January 1-October 1, 2019. Patel M, Lee AD, Clemmons NS, et al. MMWR Morb Mortal Wkly Rep. 2019;68:893–896. doi: 10.15585/mmwr.mm6840e2. \\[ [DOI](https://doi.org/10.15585/mmwr.mm6840e2)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC6788396/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/31600181/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=National%20update%20on%20measles%20cases%20and%20outbreaks%20-%20United%20States,%20January%201-October%201,%202019&volume=68&publication_year=2019&pages=893-896&pmid=31600181&doi=10.15585/mmwr.mm6840e2&)\\]\n- 8.Why have we seen an increase in measles cases? \\[\\\nJun;\\\n2025\\\n\\]. 2019\\. [https://ukhsa.blog.gov.uk/2019/08/19/measles-in-england/](https://ukhsa.blog.gov.uk/2019/08/19/measles-in-england/) [https://ukhsa.blog.gov.uk/2019/08/19/measles-in-england/](https://ukhsa.blog.gov.uk/2019/08/19/measles-in-england/)\n- 9.Measles epidemic in Samoa and other Pacific islands. Craig AT, Heywood AE, Worth H. Lancet Infect Dis. 2020;20:273–275. doi: 10.1016/S1473-3099(20)30053-0. \\[ [DOI](https://doi.org/10.1016/S1473-3099(20)30053-0)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/32112752/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect%20Dis&title=Measles%20epidemic%20in%20Samoa%20and%20other%20Pacific%20islands&volume=20&publication_year=2020&pages=273-275&pmid=32112752&doi=10.1016/S1473-3099(20)30053-0&)\\]\n- 10.Measles update - United States, January 1-April 17, 2025. Mathis AD, Raines K, Filardo TD, et al. MMWR Morb Mortal Wkly Rep. 2025;74:232–238. doi: 10.15585/mmwr.mm7414a1. \\[ [DOI](https://doi.org/10.15585/mmwr.mm7414a1)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC12021071/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/40273019/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=Measles%20update%20-%20United%20States,%20January%201-April%2017,%202025&volume=74&publication_year=2025&pages=232-238&pmid=40273019&doi=10.15585/mmwr.mm7414a1&)\\]\n- 11.Measles cases and outbreaks. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.cdc.gov/measles/data-research/index.html](https://www.cdc.gov/measles/data-research/index.html) [https://www.cdc.gov/measles/data-research/index.html](https://www.cdc.gov/measles/data-research/index.html)\n- 12.Measles data and statistics. \\[\\\nJun;\\\n2025\\\n\\]. 2019\\. [https://www.cdc.gov/measles/downloads/measlesdataandstatsslideset.pdf](https://www.cdc.gov/measles/downloads/measlesdataandstatsslideset.pdf) [https://www.cdc.gov/measles/downloads/measlesdataandstatsslideset.pdf](https://www.cdc.gov/measles/downloads/measlesdataandstatsslideset.pdf)\n- 13.Genomic analysis of Clostridioides difficile in 2 regions of the United States reveals a diversity of strains and limited transmission. Pecora N, Holzbauer S, Wang X, et al. J Infect Dis. 2022;225:121–129. doi: 10.1093/infdis/jiab294. \\[ [DOI](https://doi.org/10.1093/infdis/jiab294)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC8655013/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/34107037/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Infect%20Dis&title=Genomic%20analysis%20of%20Clostridioides%20difficile%20in%202%20regions%20of%20the%20United%20States%20reveals%20a%20diversity%20of%20strains%20and%20limited%20transmission&volume=225&publication_year=2022&pages=121-129&pmid=34107037&doi=10.1093/infdis/jiab294&)\\]\n- 14.Cara Lynn Shultz. Measles outbreak on flight to Denver sickens 3, including young child. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://people.com/measles-outbreak-turkish-airlines-flight-denver-sickens-3-including-child-11745577](https://people.com/measles-outbreak-turkish-airlines-flight-denver-sickens-3-including-child-11745577) [https://people.com/measles-outbreak-turkish-airlines-flight-denver-sickens-3-including-child-11745577](https://people.com/measles-outbreak-turkish-airlines-flight-denver-sickens-3-including-child-11745577)\n- 15.Modeling reemergence of vaccine-eliminated infectious diseases under declining vaccination in the US. Kiang MV, Bubar KM, Maldonado Y, Hotez PJ, Lo NC. JAMA. 2025;333:2176–2187. doi: 10.1001/jama.2025.6495. \\[ [DOI](https://doi.org/10.1001/jama.2025.6495)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC12022863/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/40272967/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA&title=Modeling%20reemergence%20of%20vaccine-eliminated%20infectious%20diseases%20under%20declining%20vaccination%20in%20the%20US&volume=333&publication_year=2025&pages=2176-2187&pmid=40272967&doi=10.1001/jama.2025.6495&)\\]\n- 16.The MMR vaccine and autism: sensation, refutation, retraction, and fraud. Rao TS, Andrade C. Indian J Psychiatry. 2011;53:95–96. doi: 10.4103/0019-5545.82529. \\[ [DOI](https://doi.org/10.4103/0019-5545.82529)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC3136032/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/21772639/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Indian%20J%20Psychiatry&title=The%20MMR%20vaccine%20and%20autism:%20sensation,%20refutation,%20retraction,%20and%20fraud&volume=53&publication_year=2011&pages=95-96&pmid=21772639&doi=10.4103/0019-5545.82529&)\\]\n- 17.Decline in vaccination coverage by age 24 months and vaccination inequities among children born in 2020 and 2021 - National Immunization Survey-Child, United States, 2021-2023. Hill HA, Yankey D, Elam-Evans LD, Mu Y, Chen M, Peacock G, Singleton JA. MMWR Morb Mortal Wkly Rep. 2024;73:844–853. doi: 10.15585/mmwr.mm7338a3. \\[ [DOI](https://doi.org/10.15585/mmwr.mm7338a3)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC11563569/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/39325676/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=Decline%20in%20vaccination%20coverage%20by%20age%2024%20months%20and%20vaccination%20inequities%20among%20children%20born%20in%202020%20and%202021%20-%20National%20Immunization%20Survey-Child,%20United%20States,%202021-2023&volume=73&publication_year=2024&pages=844-853&pmid=39325676&doi=10.15585/mmwr.mm7338a3&)\\]\n- 18.Wakefield's article linking MMR vaccine and autism was fraudulent. Godlee F, Smith J, Marcovitch H. BMJ. 2011;342:0. doi: 10.1136/bmj.c7452. \\[ [DOI](https://doi.org/10.1136/bmj.c7452)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/21209060/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=BMJ&title=Wakefield%27s%20article%20linking%20MMR%20vaccine%20and%20autism%20was%20fraudulent&volume=342&publication_year=2011&pages=0&pmid=21209060&doi=10.1136/bmj.c7452&)\\]\n- 19.Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Taylor LE, Swerdfeger AL, Eslick GD. Vaccine. 2014;32:3623–3629. doi: 10.1016/j.vaccine.2014.04.085. \\[ [DOI](https://doi.org/10.1016/j.vaccine.2014.04.085)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/24814559/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Vaccine&title=Vaccines%20are%20not%20associated%20with%20autism:%20an%20evidence-based%20meta-analysis%20of%20case-control%20and%20cohort%20studies&volume=32&publication_year=2014&pages=3623-3629&pmid=24814559&doi=10.1016/j.vaccine.2014.04.085&)\\]\n- 20.Measles, mumps, rubella vaccination and autism: a nationwide cohort study. Hviid A, Hansen JV, Frisch M, Melbye M. Ann Intern Med. 2019;170:513–520. doi: 10.7326/M18-2101. \\[ [DOI](https://doi.org/10.7326/M18-2101)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/30831578/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Ann%20Intern%20Med&title=Measles,%20mumps,%20rubella%20vaccination%20and%20autism:%20a%20nationwide%20cohort%20study&volume=170&publication_year=2019&pages=513-520&pmid=30831578&doi=10.7326/M18-2101&)\\]\n- 21.Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. Jain A, Marshall J, Buikema A, Bancroft T, Kelly JP, Newschaffer CJ. JAMA. 2015;313:1534–1540. doi: 10.1001/jama.2015.3077. \\[ [DOI](https://doi.org/10.1001/jama.2015.3077)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/25898051/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=JAMA&title=Autism%20occurrence%20by%20MMR%20vaccine%20status%20among%20US%20children%20with%20older%20siblings%20with%20and%20without%20autism&volume=313&publication_year=2015&pages=1534-1540&pmid=25898051&doi=10.1001/jama.2015.3077&)\\]\n- 22.Vaccination coverage and exemptions among kindergartners. \\[\\\nJun;\\\n2025\\\n\\]. 2024\\. [https://www.cdc.gov/schoolvaxview/data/index.html](https://www.cdc.gov/schoolvaxview/data/index.html) [https://www.cdc.gov/schoolvaxview/data/index.html](https://www.cdc.gov/schoolvaxview/data/index.html)\n- 23.Exploring knowledge of autism, its causes and treatment among immigrant and nonimmigrant parents in Somalia\\\\Somaliland. Duale HA, Gele A. Child Adolesc Psychiatry Ment Health. 2024;18:22. doi: 10.1186/s13034-024-00713-3. \\[ [DOI](https://doi.org/10.1186/s13034-024-00713-3)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC10851585/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/38326911/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Child%20Adolesc%20Psychiatry%20Ment%20Health&title=Exploring%20knowledge%20of%20autism,%20its%20causes%20and%20treatment%20among%20immigrant%20and%20nonimmigrant%20parents%20in%20Somalia%5CSomaliland&volume=18&publication_year=2024&pages=22&pmid=38326911&doi=10.1186/s13034-024-00713-3&)\\]\n- 24.Haelle T. Vital context to include in your measles coverage. Assoc. Health Care Journal. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://healthjournalism.org/blog/2025/05/vital-context-to-include-in-your-measles-coverage/](https://healthjournalism.org/blog/2025/05/vital-context-to-include-in-your-measles-coverage/) [https://healthjournalism.org/blog/2025/05/vital-context-to-include-in-your-measles-coverage/](https://healthjournalism.org/blog/2025/05/vital-context-to-include-in-your-measles-coverage/)\n- 25.School vaccination coverage levels - County Kindergarten Data, 2023-2024. \\[\\\nMay;\\\n2025\\\n\\]. 2024\\. [https://www.dshs.texas.gov/immunizations/data/school/coverage2015](https://www.dshs.texas.gov/immunizations/data/school/coverage2015) [https://www.dshs.texas.gov/immunizations/data/school/coverage2015](https://www.dshs.texas.gov/immunizations/data/school/coverage2015)\n- 26.Expanding measles outbreak in the United States and guidance for the upcoming travel season. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.cdc.gov/han/php/notices/han00522.html](https://www.cdc.gov/han/php/notices/han00522.html) [https://www.cdc.gov/han/php/notices/han00522.html](https://www.cdc.gov/han/php/notices/han00522.html)\n- 27.Health alert: Texas 2025 measles outbreak - expanded outbreak counties. Texas 2025 Measles Outbreak - Expanded Outbreak Counties \\| Texas DSHS. Tex. Dep. State Health Serv. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.dshs.texas.gov/news-alerts/health-alert-texas-2025-measles-outbreak-expanded-outbreak-counties](https://www.dshs.texas.gov/news-alerts/health-alert-texas-2025-measles-outbreak-expanded-outbreak-counties) [https://www.dshs.texas.gov/news-alerts/health-alert-texas-2025-measles-outbreak-expanded-outbreak-counties](https://www.dshs.texas.gov/news-alerts/health-alert-texas-2025-measles-outbreak-expanded-outbreak-counties)\n- 28.Ungar L, Smith MR. Deep cuts erode the foundations of US public health system, end progress, threaten worse to come. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://apnews.com/article/public-health-measles-rfk-maha-trump-d863f53a5d370413de8d165d5ab96e65](https://apnews.com/article/public-health-measles-rfk-maha-trump-d863f53a5d370413de8d165d5ab96e65) [https://apnews.com/article/public-health-measles-rfk-maha-trump-d863f53a5d370413de8d165d5ab96e65](https://apnews.com/article/public-health-measles-rfk-maha-trump-d863f53a5d370413de8d165d5ab96e65)\n- 29.03/12/2025 CDC issues alert for the expanding measles outbreak in the United States and guidance for the upcoming travel season. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://www.cdc.gov/locs/php/messages/2025-03-12-CDC-Issues-Alert-Expanding-Measles-Outbreak-United-States-Guidance-Upcoming-Travel-Season.html](https://www.cdc.gov/locs/php/messages/2025-03-12-CDC-Issues-Alert-Expanding-Measles-Outbreak-United-States-Guidance-Upcoming-Travel-Season.html) [https://www.cdc.gov/locs/php/messages/2025-03-12-CDC-Issues-Alert-Expanding-Measles-Outbreak-United-States-Guidance-Upcoming-Travel-Season.html](https://www.cdc.gov/locs/php/messages/2025-03-12-CDC-Issues-Alert-Expanding-Measles-Outbreak-United-States-Guidance-Upcoming-Travel-Season.html)\n- 30.Texas Department of State Health Services. Emerging and acute infectious disease guidelines. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://www.dshs.texas.gov/sites/default/files/IDCU/investigation/electronic/EAIDG/2025/EAIDG-2025-03-10-2025.pdf](https://www.dshs.texas.gov/sites/default/files/IDCU/investigation/electronic/EAIDG/2025/EAIDG-2025-03-10-2025.pdf) [https://www.dshs.texas.gov/sites/default/files/IDCU/investigation/electronic/EAIDG/2025/EAIDG-2025-03-10-2025.pdf](https://www.dshs.texas.gov/sites/default/files/IDCU/investigation/electronic/EAIDG/2025/EAIDG-2025-03-10-2025.pdf)\n- 31.Salhotra BP. With crumbling public health infrastructure, rural Texas scrambles to respond to measles. Tex. Trib. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://www.texastribune.org/2025/03/10/rural-texas-measles-outbreak-response/](https://www.texastribune.org/2025/03/10/rural-texas-measles-outbreak-response/) [https://www.texastribune.org/2025/03/10/rural-texas-measles-outbreak-response/](https://www.texastribune.org/2025/03/10/rural-texas-measles-outbreak-response/)\n- 32.Schreiber M. Texas cities run short of MMR vaccine as measles outbreak drives demand. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://www.theguardian.com/us-news/2025/mar/08/texas-mmr-vaccine-measles-outbreak](https://www.theguardian.com/us-news/2025/mar/08/texas-mmr-vaccine-measles-outbreak) [https://www.theguardian.com/us-news/2025/mar/08/texas-mmr-vaccine-measles-outbreak](https://www.theguardian.com/us-news/2025/mar/08/texas-mmr-vaccine-measles-outbreak)\n- 33.2023 Immunization Profile Study. 2023 immunization profile study. \\[\\\nJul;\\\n2025\\\n\\]. 2023\\. [https://www.naccho.org/uploads/downloadable-resources/2023-Immunization-Profile-Study.pdf](https://www.naccho.org/uploads/downloadable-resources/2023-Immunization-Profile-Study.pdf) [https://www.naccho.org/uploads/downloadable-resources/2023-Immunization-Profile-Study.pdf](https://www.naccho.org/uploads/downloadable-resources/2023-Immunization-Profile-Study.pdf)\n- 34.Measles exposure at a large gathering in Kentucky, February 2023 and global measles outbreaks. \\[\\\nJul;\\\n2025\\\n\\]. 2023\\. [https://www.cdc.gov/han/2023/han00488.html](https://www.cdc.gov/han/2023/han00488.html) [https://www.cdc.gov/han/2023/han00488.html](https://www.cdc.gov/han/2023/han00488.html)\n- 35.Societal costs of a measles outbreak. Pike J, Melnick A, Gastañaduy PA, et al. Pediatrics. 2021;147:0. doi: 10.1542/peds.2020-027037. \\[ [DOI](https://doi.org/10.1542/peds.2020-027037)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC9004490/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/33712549/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatrics&title=Societal%20costs%20of%20a%20measles%20outbreak&volume=147&publication_year=2021&pages=0&pmid=33712549&doi=10.1542/peds.2020-027037&)\\]\n- 36.The economic impact of the ongoing measles outbreak. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://publichealth.jhu.edu/ivac/2025/economic-impact-of-the-ongoing-measles-outbreak](https://publichealth.jhu.edu/ivac/2025/economic-impact-of-the-ongoing-measles-outbreak) [https://publichealth.jhu.edu/ivac/2025/economic-impact-of-the-ongoing-measles-outbreak](https://publichealth.jhu.edu/ivac/2025/economic-impact-of-the-ongoing-measles-outbreak)\n- 37.Measles. \\[\\\nJun;\\\n2025\\\n\\]. 2024\\. [https://www.who.int/news-room/fact-sheets/detail/measles](https://www.who.int/news-room/fact-sheets/detail/measles) [https://www.who.int/news-room/fact-sheets/detail/measles](https://www.who.int/news-room/fact-sheets/detail/measles)\n- 38.General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP) Rep. \\[\\\nJun;\\\n2025\\\n\\]. 2002\\. [https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm). [https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm](https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5102a1.htm) \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/11848294/)\\]\n- 39.Impact of achieving WHO's 90-70-90 targets on cervical cancer elimination and potential benefits in preventing other HPV-related cancers in China: a modelling study. Zou Z, Fairley CK, Ong JJ, et al. EClinicalMedicine. 2024;77:102878. doi: 10.1016/j.eclinm.2024.102878. \\[ [DOI](https://doi.org/10.1016/j.eclinm.2024.102878)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC11701475/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/39763509/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&title=Impact%20of%20achieving%20WHO%27s%2090-70-90%20targets%20on%20cervical%20cancer%20elimination%20and%20potential%20benefits%20in%20preventing%20other%20HPV-related%20cancers%20in%20China:%20a%20modelling%20study&volume=77&publication_year=2024&pages=102878&pmid=39763509&doi=10.1016/j.eclinm.2024.102878&)\\]\n- 40.COVID-19-associated hospitalizations and maternal vaccination among infants aged < 6 months - COVID-NET, 12 States, October 2022-April 2024. Havers FP, Whitaker M, Chatwani B, et al. MMWR Morb Mortal Wkly Rep. 2024;73:830–836. doi: 10.15585/mmwr.mm7338a1. \\[ [DOI](https://doi.org/10.15585/mmwr.mm7338a1)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC11563568/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/39325677/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=MMWR%20Morb%20Mortal%20Wkly%20Rep&title=COVID-19-associated%20hospitalizations%20and%20maternal%20vaccination%20among%20infants%20aged%20%3C%206%20months%20-%20COVID-NET,%2012%20States,%20October%202022-April%202024&volume=73&publication_year=2024&pages=830-836&pmid=39325677&doi=10.15585/mmwr.mm7338a1&)\\]\n- 41.California’s vaccination exemptions cluster in white, affluent communities. Stanf. Health Policy. \\[\\\nJul;\\\n2025\\\n\\]. 2015\\. [https://healthpolicy.fsi.stanford.edu/news/californias-vaccination-exemptions-cluster-white-affluent-communities](https://healthpolicy.fsi.stanford.edu/news/californias-vaccination-exemptions-cluster-white-affluent-communities) [https://healthpolicy.fsi.stanford.edu/news/californias-vaccination-exemptions-cluster-white-affluent-communities](https://healthpolicy.fsi.stanford.edu/news/californias-vaccination-exemptions-cluster-white-affluent-communities)\n- 42.Mary Ann Barton. Measles outbreak underscores rural healthcare challenges. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.naco.org/news/measles-outbreak-underscores-rural-healthcare-challenges](https://www.naco.org/news/measles-outbreak-underscores-rural-healthcare-challenges) [https://www.naco.org/news/measles-outbreak-underscores-rural-healthcare-challenges](https://www.naco.org/news/measles-outbreak-underscores-rural-healthcare-challenges)\n- 43.Zero-dose children, misinformation, and vaccine hesitancy. Nashwan AJ, Abuhammad S. Cureus. 2025;17:0. doi: 10.7759/cureus.82028. \\[ [DOI](https://doi.org/10.7759/cureus.82028)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC12065619/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/40351967/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cureus&title=Zero-dose%20children,%20misinformation,%20and%20vaccine%20hesitancy&volume=17&publication_year=2025&pages=0&pmid=40351967&doi=10.7759/cureus.82028&)\\]\n- 44.Nonmedical exemptions from school immunization requirements: a systematic review. Wang E, Clymer J, Davis-Hayes C, Buttenheim A. Am J Public Health. 2014;104:0–84. doi: 10.2105/AJPH.2014.302190. \\[ [DOI](https://doi.org/10.2105/AJPH.2014.302190)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC4202987/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/25211732/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Am%20J%20Public%20Health&title=Nonmedical%20exemptions%20from%20school%20immunization%20requirements:%20a%20systematic%20review&volume=104&publication_year=2014&pages=0-84&pmid=25211732&doi=10.2105/AJPH.2014.302190&)\\]\n- 45.Elimination of nonmedical immunization exemptions in California and school-entry vaccine status. Delamater PL, Pingali SC, Buttenheim AM, Salmon DA, Klein NP, Omer SB. Pediatrics. 2019;143:0. doi: 10.1542/peds.2018-3301. \\[ [DOI](https://doi.org/10.1542/peds.2018-3301)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC6564056/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/31113831/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Pediatrics&title=Elimination%20of%20nonmedical%20immunization%20exemptions%20in%20California%20and%20school-entry%20vaccine%20status&volume=143&publication_year=2019&pages=0&pmid=31113831&doi=10.1542/peds.2018-3301&)\\]\n- 46.Impact of community volunteers on immunization rates of children younger than 2 years. Barnes K, Friedman SM, Brickner Namerow P, Honig J. Arch Pediatr Adolesc Med. 1999;153:518–524. doi: 10.1001/archpedi.153.5.518. \\[ [DOI](https://doi.org/10.1001/archpedi.153.5.518)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/10323634/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Arch%20Pediatr%20Adolesc%20Med&title=Impact%20of%20community%20volunteers%20on%20immunization%20rates%20of%20children%20younger%20than%202%20years&volume=153&publication_year=1999&pages=518-524&pmid=10323634&doi=10.1001/archpedi.153.5.518&)\\]\n- 47.Platoff BE. As coronavirus cases surged, Texas’ contact tracing workforce shrunk. Tex. Trib. \\[\\\nJul;\\\n2025\\\n\\]. 2020\\. [https://www.texastribune.org/2020/06/30/texas-cut-contact-tracing/](https://www.texastribune.org/2020/06/30/texas-cut-contact-tracing/) [https://www.texastribune.org/2020/06/30/texas-cut-contact-tracing/](https://www.texastribune.org/2020/06/30/texas-cut-contact-tracing/)\n- 48.Mary Van Beusekom, MS MS. 'On the precipice of disaster': measles may be endemic in 25 years if vaccine uptake stays low, model predicts. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.cidrap.umn.edu/measles/precipice-disaster-measles-may-be-endemic-25-years-if-vaccine-uptake-stays-low-model](https://www.cidrap.umn.edu/measles/precipice-disaster-measles-may-be-endemic-25-years-if-vaccine-uptake-stays-low-model) [https://www.cidrap.umn.edu/measles/precipice-disaster-measles-may-be-endemic-25-years-if-vaccine-uptake-stays-low-model](https://www.cidrap.umn.edu/measles/precipice-disaster-measles-may-be-endemic-25-years-if-vaccine-uptake-stays-low-model)\n- 49.Measles and rubella strategic framework: 2021-2030. \\[\\\nJun;\\\n2025\\\n\\]. 2020\\. [https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030](https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030) [https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030](https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030)\n- 50.Vaccine misinformation outpaces efforts to counter it. Columbia Univ. Mail. Sch. Public Health. \\[\\\nJun;\\\n2025\\\n\\]. 2024\\. [https://www.publichealth.columbia.edu/news/vaccine-misinformation-outpaces-efforts-counter-it](https://www.publichealth.columbia.edu/news/vaccine-misinformation-outpaces-efforts-counter-it) [https://www.publichealth.columbia.edu/news/vaccine-misinformation-outpaces-efforts-counter-it](https://www.publichealth.columbia.edu/news/vaccine-misinformation-outpaces-efforts-counter-it)\n- 51.A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. Adigweme I, Yisa M, Ooko M, et al. Lancet. 2024;403:1879–1892. doi: 10.1016/S0140-6736(24)00532-4. \\[ [DOI](https://doi.org/10.1016/S0140-6736(24)00532-4)\\] \\[ [PMC free article](https://pmc.ncbi.nlm.nih.gov/articles/PMC11099471/)\\] \\[ [PubMed](https://pubmed.ncbi.nlm.nih.gov/38697170/)\\] \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Lancet&title=A%20measles%20and%20rubella%20vaccine%20microneedle%20patch%20in%20The%20Gambia:%20a%20phase%201/2,%20double-blind,%20double-dummy,%20randomised,%20active-controlled,%20age%20de-escalation%20trial&volume=403&publication_year=2024&pages=1879-1892&pmid=38697170&doi=10.1016/S0140-6736(24)00532-4&)\\]\n- 52.Maintain the vaccination coverage level of 2 doses of the MMR vaccine for children in kindergarten - IID‑04. Off. Dis. Prev. Health Promot. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/maintain-vaccination-coverage-level-2-doses-mmr-vaccine-children-kindergarten-iid-04](https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/maintain-vaccination-coverage-level-2-doses-mmr-vaccine-children-kindergarten-iid-04) [https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/maintain-vaccination-coverage-level-2-doses-mmr-vaccine-children-kindergarten-iid-04](https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/maintain-vaccination-coverage-level-2-doses-mmr-vaccine-children-kindergarten-iid-04)\n- 53.7-1-7: a global target for early detection & response. \\[\\\nJul;\\\n2025\\\n\\]; [https://resolvetosavelives.org/epidemic-prevention/7-1-7](https://resolvetosavelives.org/epidemic-prevention/7-1-7) 2025 2025:7–1. \\[ [Google Scholar](https://scholar.google.com/scholar_lookup?7-1-7:%20a%20global%20target%20for%20early%20detection%20&%20response.%20%5B%20Jul;%202025%20%5D;https://resolvetosavelives.org/epidemic-prevention/7-1-7%202025%202025:7%E2%80%931.)\\]\n- 54.Maine celebrates record high immunization rates among school children; prepares for statewide implementation of docket for schools. \\[\\\nJul;\\\n2025\\\n\\]. 2025\\. [https://www.maine.gov/dhhs/news/maine-celebrates-record-high-immunization-rates-among-school-children-prepares-statewide-fri-06062025-1200.](https://www.maine.gov/dhhs/news/maine-celebrates-record-high-immunization-rates-among-school-children-prepares-statewide-fri-06062025-1200.) [https://www.maine.gov/dhhs/news/maine-celebrates-record-high-immunization-rates-among-school-children-prepares-statewide-fri-06062025-1200.](https://www.maine.gov/dhhs/news/maine-celebrates-record-high-immunization-rates-among-school-children-prepares-statewide-fri-06062025-1200.)\n- 55.Prevention & response. \\[\\\nJun;\\\n2025\\\n\\]. 2025\\. [https://www.cdc.gov/global-health/annual-report-2024/prevention-response.html](https://www.cdc.gov/global-health/annual-report-2024/prevention-response.html) [https://www.cdc.gov/global-health/annual-report-2024/prevention-response.html](https://www.cdc.gov/global-health/annual-report-2024/prevention-response.html)\n\n![Close](https://pmc.ncbi.nlm.nih.gov/static/img/usa-icons/close.svg)\n\n## ACTIONS\n\n- [View on publisher site](https://doi.org/10.7759/cureus.88196)\n- [PDF (1.2 MB)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12357784/pdf/cureus-0017-00000088196.pdf)\n- Cite\n- Collections\n- Permalink\n\n\n\n\n## PERMALINK\n\n\n\nCopy\n\n\n## RESOURCES\n\n### Similar articles\n\n### Cited by other articles\n\n### Links to NCBI Databases\n\nBack to Top",
    "query": "measles misdiagnosis rubella USA 2025"
  },
  {
    "snippet": "Accessibility links\n\n- [Skip to main content](https://www.npr.org/sections/shots-health-news/2025/04/23/nx-s1-5372760/measles-misinformation-poll#mainContent)\n- [Keyboard shortcuts for audio player](https://help.npr.org/contact/s/article?name=what-are-the-keyboard-shortcuts-for-using-the-npr-org-audio-player)\n\n**Play Live Radio**\n\n- **Hourly News**\n- **Listen Live**\n- **My Playlist**\n\n**As measles spreads, new poll finds misinformation is having an impact. : Shots - Health News** **With the U.S....",
    "content": "Accessibility links\n\n- [Skip to main content](https://www.npr.org/sections/shots-health-news/2025/04/23/nx-s1-5372760/measles-misinformation-poll#mainContent)\n- [Keyboard shortcuts for audio player](https://help.npr.org/contact/s/article?name=what-are-the-keyboard-shortcuts-for-using-the-npr-org-audio-player)\n\n**Play Live Radio**\n\n- **Hourly News**\n- **Listen Live**\n- **My Playlist**\n\n**As measles spreads, new poll finds misinformation is having an impact. : Shots - Health News** **With the U.S. now reporting more than 800 measles cases, a new poll from health policy research group KFF finds that many people are being exposed to false claims about measles and the measles vaccine.**\n\n### [Shots - Health News](https://www.npr.org/sections/health-shots/)\n\n# Like measles, misinformation is spreading, poll finds\n\nApril 23, 20255:00 AM ET\n\nHeard on [Morning Edition](https://www.npr.org/programs/morning-edition/2025/04/23/morning-edition-for-april-23-2025)\n\n[![Maria Godoy at NPR headquarters in Washington, D.C., May 22, 2018. (photo by Allison Shelley) (Square)](https://media.npr.org/assets/img/2018/08/21/npr_98035461_sq-a75bcf8508e2ffb3e5b0c1c27e7a603eb96eef69.jpg?s=100&c=85&f=jpeg)](https://www.npr.org/people/348777820/maria-godoy)\n\n[Maria Godoy](https://www.npr.org/people/348777820/maria-godoy)\n\n#### Like measles, misinformation is spreading, poll finds\n\n**Listen· 1:57**1-Minute Listen**Playlist**\n\n[**Transcript**](https://www.npr.org/transcripts/nx-s1-5372760)**Toggle more options**\n\n- [**Download**](https://ondemand.npr.org/anon.npr-mp3/npr/me/2025/04/20250423_me_like_measles_misinformation_is_spreading_poll_finds.mp3?size=1885876&d=117814&e=nx-s1-5372760&sc=siteplayer&aw_0_1st.playerid=siteplayer)\n- **Embed**\n**Embed****`<iframe src=\"https://www.npr.org/player/embed/nx-s1-5372760/nx-s1-5434544-1\" width=\"100%\" height=\"290\" frameborder=\"0\" scrolling=\"no\" title=\"NPR embedded audio player\">`**\n\n- [**Transcript**](https://www.npr.org/transcripts/nx-s1-5372760)\n\n![Parents who believed a false claim about measles were more likely to skip or delay childhood vaccinations, a new poll finds.](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/2424x1236+0+0/resize/1100/quality/50/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fe2%2F77%2F3eee4b494bf9a0f90ce41180e1f8%2Fgettyimages-2209760517.jpg)\n\nA KFF poll found parents who believed a false claim about measles were more likely to skip or delay childhood vaccinations.\n**wildpixel/Getty Images** **hide caption**\n\n**toggle caption**\n\n\nwildpixel/Getty Images\n\n\n\nThe U.S. has now reported more than 800 measles cases in at least two dozen states. The vast majority of cases — more than 600 — are in Texas. In the midst of the outbreak, a [new poll](https://www.kff.org/other/poll-finding/kff-tracking-poll-on-health-information-and-trust-the-publics-views-on-measles-outbreaks-and-misinformation) shows how much misinformation people are seeing about measles.\n\nThe good news is the vast majority of people still have [confidence in the safety](https://www.npr.org/sections/shots-health-news/2025/03/30/nx-s1-5343997/measles-vaccine-hesitancy-enthusiasm-outbreaks) of the measles vaccine, says [Liz Hamel](https://www.kff.org/person/liz-hamel/), director of public opinion and survey research at KFF, a nonprofit health policy research organization which conducted the poll.\n\nThe bad news: People are being exposed to a lot of [false claims about measles](https://www.npr.org/2025/04/14/1244690933/vaccine-expert-worries-child-measles-deaths-are-being-normalized)— and many don't know what to make of it.\n\n\"What we have seen is that a large share of people are at least somewhat uncertain about how to evaluate that misinformation,\" Hamel says.\n\nThe survey was conducted earlier in April and included a nationally representative sample of 1,380 adults. Pollsters asked respondents about three false claims: that the measles vaccine is more dangerous than getting the disease; that the vaccine causes autism in children, and that vitamin A can prevent a measles infection. None of these things are true.\n\n[![A second death has been confirmed in the measles outbreak in west Texas. An unvaccinated adult tested positive for the virus across the border in New Mexico.](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/683x683+123+0/resize/100/quality/85/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F7d%2Ffb%2F7285351d4ca8b1807fbc9e0e4de9%2Fgettyimages-2201702412.jpg)](https://www.npr.org/2025/03/07/nx-s1-5320352/measles-rfk-west-texas-outbreak)\n\n### [Health](https://www.npr.org/sections/health/)\n\n### [Amid a growing measles outbreak, doctors worry RFK Jr. is sending the wrong message](https://www.npr.org/2025/03/07/nx-s1-5320352/measles-rfk-west-texas-outbreak)\n\nOnly 5 percent of adults polled said they thought these falsehoods were definitely true, and a much larger share of respondents said they were \"probably false\" — but they weren't completely confident that these were falsehoods. Hamel says that shows there's a large group of people out there whose views on measles have room for uncertainty.\n\nAnd a significant proportion leaned toward saying these false claims about measles are probably true. For example, 1 in 4 adults polled said vitamin A either probably or definitely prevents measles. And 19% believed it was probably or definitely true that the measles, mumps and rubella vaccine is more dangerous than getting infected with measles.\n\nThe poll also found a clear political divide.\n\n\"We see that Republicans are much more likely than Democrats to lean towards believing this misinformation about measles,\" Hamel says. \"And that's true among parents as well.\"\n\nMost parents in the poll said they do keep their children up to date on their recommended vaccines.\n\nBut among parents who said that at least one of these false claims was probably or definitely true, 1 in 4 said they'd either skipped or delayed some recommended vaccines for their kids.\n\n[![Most kids recover from measles. But the virus can be deadly and can erase the immune system's memory.](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/2053x2053+537+0/resize/100/quality/85/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F0d%2F11%2F9cf6d5f8418b962716e6a152ad14%2Fgettyimages-1266944621.jpg)](https://www.npr.org/sections/shots-health-news/2025/03/17/nx-s1-5328765/measles-outbreak-health-risk)\n\n### [Shots - Health News](https://www.npr.org/sections/health-shots/)\n\n### [Measles remains a danger to health even years after an infection](https://www.npr.org/sections/shots-health-news/2025/03/17/nx-s1-5328765/measles-outbreak-health-risk)\n\n\"Those parents are more than twice as likely to say that they have delayed or skipped some vaccines for their children compared to parents who don't believe any of those claims,\" Hamel says, adding, \"I think this is one of the more concerning findings from the poll.\"\n\nHamel says one big takeaway is that in a world where people are bombarded with health information — and misinformation — on all kinds of media platforms, they don't always know how to evaluate what they're hearing or reading or who to trust.\n\n_Edited by Jane Greenhalgh_\n\n- [measles](https://www.npr.org/tags/136620805/measles)\n- [misinformation](https://www.npr.org/tags/526365411/misinformation)\n- [new poll](https://www.npr.org/tags/347079773/new-poll)\n\n- **Facebook**\n- **Flipboard**\n- **Email**\n\n![NPR Plus logo](https://prod-eks-static-assets.npr.org/chrome_svg/npr-plus/npr-plus-combo-logo.svg)\n\n##### Exclusive benefits\n\n###### Give a little. Get a lot.\n\nSupport mission-driven journalism while getting something great in return. Enjoy bonus content, early access and sponsor-free listening from your favorite NPR podcasts.\n\n[Get NPR+](https://plus.npr.org/?utm_medium=nprweb&source=mvpcta)\n\nAlready have NPR+? [Sign In](https://www.npr.org/sections/shots-health-news/2025/04/23/nx-s1-5372760/measles-misinformation-poll#)\n\nClose modal\n\n![NPR logo](https://cdn.cookielaw.org/logos/26b1c6a2-1285-46a9-a3af-3a0d7ddde52e/82089dfe-410c-4e1b-a7f9-698174b62a86/12f4304d-661a-4de3-80ce-82f3165cfb61/NPR_Logo_Color.png)\n\n## Privacy Preference Center\n\nNPR and our service providers and vendors use cookies and similar technologies to collect information. A cookie is a string of characters that can be written to a file on the user's computer or device when the user visits a site, application, platform or service. When you visit a website or use a mobile application, a computer asks your computer or mobile device for permission to store this file on your computer or mobile device and access information from it. Information gathered through cookies may include the date and time of visits and how you are using the website. Note that if you disable or delete cookies, you may lose access to certain features of the NPR Services.\n\nUser ID:  51553898-fc22-4025-a5e9-f84c14bd03a9\n\nThis User ID will be used as a unique identifier while storing and accessing your preferences for future.\n\nTimestamp:  --\n\nAllow All\n\n### Manage Consent Preferences\n\n#### Strictly Necessary or Essential Cookies\n\nAlways Active\n\nThese cookies are essential to provide you with services available through the NPR Services and to enable you to use some of their features. For example, these cookies allow NPR to remember your registration information while you are logged in. Local station customization, the NPR Shop, and other interactive features also use cookies. Without these cookies, the services that you have asked for cannot be provided, and we only use these cookies to provide you with those services.\n\n#### Performance and Analytics Cookies\n\nPerformance and Analytics Cookies\n\nThese cookies are used to collect information about traffic to our Services and how users interact with the NPR Services. The information collected includes the number of visitors to the NPR Services, the websites that referred visitors to the NPR Services, the pages that they visited on the NPR Services, what time of day they visited the NPR Services, whether they have visited the NPR Services before, and other similar information. We use this information to help operate the NPR Services more efficiently, to gather broad demographic information and to monitor the level of activity on the NPR Services.\n\n#### Functional Cookies\n\nFunctional Cookies\n\nThese cookies allow our Services to remember choices you make when you use them, such as remembering your Member station preferences and remembering your account details. The purpose of these cookies is to provide you with a more personal experience and to prevent you from having to re-enter your preferences every time you visit the NPR Services.\n\n#### Targeting and Sponsor Cookies\n\nTargeting and Sponsor Cookies\n\nThese cookies track your browsing habits or other information, such as location, to enable us to show sponsorship credits which are more likely to be of interest to you. These cookies use information about your browsing history to group you with other users who have similar interests. Based on that information, and with our permission, we and our sponsors can place cookies to enable us or our sponsors to show sponsorship credits and other messages that we think will be relevant to your interests while you are using third-party services.\n\nBack Button\n\n### Cookie List\n\nSearch Icon\n\nFilter Icon\n\nClear\n\ncheckbox labellabel\n\nApplyCancel\n\nConsentLeg.Interest\n\ncheckbox labellabel\n\ncheckbox labellabel\n\ncheckbox labellabel\n\nReject AllConfirm My Choices\n\n[![Powered by Onetrust](https://cdn.cookielaw.org/logos/static/powered_by_logo.svg)](https://www.onetrust.com/products/cookie-consent/)\n\nreCAPTCHA\n\nRecaptcha requires verification.\n\n[Privacy](https://www.google.com/intl/en/policies/privacy/) \\- [Terms](https://www.google.com/intl/en/policies/terms/)\n\nprotected by **reCAPTCHA**\n\nreCAPTCHA is changing its terms of service. [Take action.](https://google.com/recaptcha/admin/migrate)\n\n[Privacy](https://www.google.com/intl/en/policies/privacy/) \\- [Terms](https://www.google.com/intl/en/policies/terms/)\n\nStripeM-Inner",
    "query": "measles misdiagnosis rubella USA 2025"
  },
  {
    "snippet": "[Skip directly to search](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#headerSearch)\n\n[Español](https://www.cdc.gov/spanish/) \\| [Other Languages](https://wwwn.cdc.gov/pubs/other-languages/)\n\n![](https://www.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png)An official website of the United States government Here's how you know\n\n![](https://www.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg)\n\n**Official websites use .gov**\n\nA .gov website belongs to an offici...",
    "content": "[Skip directly to search](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#headerSearch)\n\n[Español](https://www.cdc.gov/spanish/) \\| [Other Languages](https://wwwn.cdc.gov/pubs/other-languages/)\n\n![](https://www.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/us_flag_small.png)An official website of the United States government Here's how you know\n\n![](https://www.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-dot-gov.svg)\n\n**Official websites use .gov**\n\nA .gov website belongs to an official government organization in the United States.\n\n![](https://www.cdc.gov/TemplatePackage/4.0/assets/imgs/uswds/icon-https.svg)\n\n**Secure .gov websites use HTTPS**\n\nA lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.\n\n# Measles Update — United States, January 1–April 17, 2025\n\n_Weekly_ / April 24, 2025 / 74(14);232–238\n\n[Print](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#print)\n\n[plus](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#collapse_116038685aaef946962)\n\nRelated Pages\n\nAdria D. Mathis, MSPH1; Kelley Raines, MPH1; Thomas D. Filardo, MD1; Nicole Wiley, MPH2; Jessica Leung, MPH1; Paul A. Rota, PhD1; Diana Martinez, PhD3; Saroj Rai, PhD3; Varun Shetty, MD3; Nora Holzinger, MA, MPH4; Emma Stanislawski, MPH4; Demetre C. Daskalakis, MD5; Kevin Chatham-Stephens, MD6; Manisha Patel, MD5; David Sugerman, MD1 ( [View author affiliations](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#contribAff))\n\n[View suggested citation](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#suggestedcitation)\n\n### **Summary**\n\n**What is already known about this topic?**\n\nAlthough measles was declared eliminated in the United States in 2000, large outbreaks with 50 or more cases have become more frequent, especially in close-knit communities with low vaccination coverage.\n\n**What is added by this report?**\n\nDuring January 1–April 17, 2025, a total of 800 measles cases were reported in the United States, the second highest annual case count in 25 years; 82% were associated with an ongoing outbreak in close-knit communities with low vaccination coverage in New Mexico, Oklahoma, and Texas. Eighty-five (11%) patients were hospitalized, and three have died.\n\n**What are the implications for public health practice?**\n\nTo prepare for and prevent measles cases and outbreaks, health departments should work with trusted messengers on culturally competent community engagement, education, vaccination efforts, and other infection prevention approaches. Increasing national and local measles, mumps, and rubella vaccination coverage is essential to preventing measles cases and outbreaks.\n\nArticle Metrics\n\n##### Altmetric:\n\n[![Article has an altmetric score of 1393](https://badges.altmetric.com/?size=128&score=1393&types=mmbvtfuo)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340)\n\n[See more details](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340)\n\n[News (154)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=news)\n\n[Blogs (9)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=blogs)\n\n[X (140)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=twitter)\n\n[Facebook (2)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=facebook)\n\n[Video (1)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=video)\n\n[Bluesky (87)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=bluesky)\n\n[Podcasts (2)](https://www.altmetric.com/details.php?domain=www.cdc.gov&citation_id=176418340&tab=podcasts)\n\nMendeley (24)\n\n\n[23\\\\\n\\\\\nCITATIONS\\\\\n\\\\\n![23 total citations on Dimensions.](https://badge.dimensions.ai/badge?count=23)\\\\\n\\\\\n23Total citations\\\\\n\\\\\n23Recent citations\\\\\n\\\\\nn/aField Citation Ratio\\\\\n\\\\\nn/aRelative Citation Ratio](https://badge.dimensions.ai/details/doi/10.15585/mmwr.mm7414a1?domain=https://www.cdc.gov)\n\n**Figures**\n\n[Figure 1](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#F1_down)\n\n[Figure 2](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#F2_down)\n\n[**Table**](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#T1_down)\n\nRelated Materials\n\n- [Article PDF](https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7414a1-H.pdf)\n- [Full Issue PDF](https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7414-H.pdf)\n\n## Abstract\n\nA multistate measles outbreak, predominantly affecting members of close-knit communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas began in January 2025. As of April 17, a total of 800 cases have been reported in the United States in 2025; 654 (82%) cases in New Mexico, Oklahoma, and Texas have been associated with the ongoing outbreak. These cases represent an approximately 180% increase over the 285 measles cases reported in the United States during all of 2024, and the second highest annual case count in the United States in 25 years. Overall, 771 (96%) patients have been unvaccinated or had unknown vaccination status (77% were unvaccinated, and 14% had unknown vaccination status when excluding 590 cases reported by Texas, which requires explicit consent by law \\[i.e., opt-in\\] to enroll in the Texas Immunization Registry), 85 (11%) patients have been hospitalized, and three patients have died. Among 48 (6%) internationally imported cases, 44 (92%) occurred among U.S. residents. Endemic measles was declared eliminated in the United States in 2000 as a direct result of high 2-dose childhood coverage with the measles, mumps, and rubella (MMR) vaccine. However, measles cases and outbreaks continue to occur when travelers with measles return to the United States while they are infectious; larger U.S. outbreaks typically follow importation into close-knit communities with low vaccination coverage. Nationally, risk for widespread measles transmission remains low because of high population-level immunity. To prepare for and prevent measles cases and outbreaks, public health departments should continue working with trusted community messengers on culturally competent community engagement, education, vaccination efforts, and other community infection prevention approaches (e.g., case isolation, contact monitoring, and post-exposure prophylaxis) and coordinating with health care facilities and schools. Increasing national and local MMR vaccination coverage is essential to preventing measles cases and outbreaks.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n## Introduction\n\nMeasles is the most highly contagious febrile rash illness, infecting up to 90% of susceptible close contacts and resulting in serious complications such as pneumonia, encephalitis, and death. Among the 4,056 measles cases reported in the United States during 2001–2022, a total of 727 (18%) were hospitalized, and three deaths were reported\\*; of the 727 hospitalized patients, 473 (65%) were unvaccinated, and 187 (26%) had unknown vaccination status ( _1_). Worldwide, measles vaccination is estimated to have saved 93.7 million lives during 1974–2024 and played a substantial role in reducing childhood mortality ( _2_) by preventing complications associated with measles and deaths from other infectious diseases as a consequence of measles-related immunosuppression ( _3_).\n\nEndemic measles transmission was declared eliminated† in the United States in 2000 after a change from a 1-dose to a 2-dose measles, mumps, and rubella (MMR) vaccination schedule in 1989 ( _4_). However, a recent resurgence in global measles, resulting from COVID-19 pandemic–related challenges in implementing measles vaccination routine services and campaigns, has increased the risk for imported cases and outbreaks in the United States, particularly when U.S. travelers are exposed to measles abroad and return to the United States while they are infectious ( _5_). Although the United States still benefits from high population immunity from routine MMR vaccination, declining immunization rates among school-aged children and communities with already low vaccination coverage threaten a resurgence of measles, along with its potentially serious associated complications. For this report, CDC used national surveillance data to describe the epidemiology of measles cases and outbreaks reported in the United States during the first 16 weeks of 2025.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n## Methods\n\n### Data Source and Case Classification\n\nState health departments notify CDC of confirmed measles cases§ ( _6_) through the National Notifiable Diseases Surveillance System and directly (by email or telephone) to the National Center for Immunization and Respiratory Diseases. Measles vaccination status is ascertained by health departments during each case investigation; patients with written or electronic documentation of receipt of ≥1 dose of a measles-containing vaccine ≥14 days before rash onset are considered vaccinated, and all other patients are classified as unvaccinated or as having unknown measles vaccination status.¶ Measles cases are classified by the Council of State and Territorial Epidemiologists as internationally imported if 1) at least part of the exposure period (7–21 days before rash onset) occurred outside the United States, 2) rash onset occurred within 21 days of entering the United States, and 3) no known exposure to measles occurred in the United States. All other cases are classified as U.S.-acquired ( _6_). For this analysis, patients with imported measles cases were classified as age-eligible for vaccination if they were aged ≥6 months and were not vaccinated according to Advisory Committee on Immunization Practices (ACIP) recommendations ( _4_).\n\n### Analysis of Outbreaks\n\nA measles outbreak was defined as the occurrence of three or more epidemiologically linked\\*\\* cases. Unique measles virus sequences are defined as those differing by at least one nucleotide in the N-450 sequence (i.e., the 450 nucleotides encoding the carboxyl-terminal 150 nucleoprotein amino acids) based on standard World Health Organization recommendations for describing sequence variants†† ( _7_). Patients with confirmed vaccine reactions (i.e., rash caused by a reaction to vaccine strain virus) were not included as persons with measles cases, as studies have found no confirmed instances of human-to-human transmission of the measles vaccine strain virus ( _6_). This activity was reviewed by CDC, deemed not research, and was conducted consistent with applicable federal law and CDC policy.§§\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n## Results\n\n### Characteristics of Reported Measles Cases\n\nDuring January 1–April 17, 2025, a total of 800 confirmed measles cases were reported in 25 U.S. jurisdictions ( [Figure 1](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#F1_down)). The highest number of weekly cases (99) was reported during the week ending March 22 ( [Figure 2](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#F2_down)). Median patient age was 9 years (IQR = 4–23 years); 249 (31%) patients were aged <5 years, 304 (38%) were aged 5–19 years, 231 (29%) were aged ≥20 years, and age was unknown for 16 (2%) patients ( [Table](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#T1_down)). Among all measles patients, 771 (96%) were unvaccinated or their vaccination status was unknown, 10 (1%) had received 1 dose of MMR vaccine, and 19 (2%) had received 2 doses. For Texas cases, it was not possible to disaggregate unvaccinated patients from those with unknown vaccination status because the Texas Immunization Registry requires explicit consent by law (i.e., opt-in) to enroll. Among 210 measles patients (excluding 590 cases reported by Texas), 162 (77%) were unvaccinated, six (3%) had received 1 dose of MMR vaccine, 12 (6%) had received 2 doses, and the vaccination status of 30 (14%) was unknown. Among all 800 cases, 790 (99%) occurred among U.S. residents. Overall, 85 (11%) patients were hospitalized; 56 (66%) of those were unvaccinated, one (1%) had received 1 dose of MMR vaccine, and the vaccination status of 28 (33%) was unknown. Three measles deaths were reported to CDC; two confirmed in Texas in unvaccinated school-aged children with no known underlying medical conditions, and one confirmed in New Mexico in an unvaccinated adult. Most cases (557; 70%) were laboratory-confirmed; among 251 (31%) cases from which specimens were available for molecular sequencing, all were confirmed as wild-type virus strain with 225 (90%) identified as genotype D8 and 26 (10%) as genotype B3.\n\n### International Importations\n\nForty-eight (6%) cases were directly imported from other countries, including 44 (92%) among U.S. residents who had traveled abroad; 752 (94%) cases were U.S.-acquired. Fifteen (31%) importations resulted in secondary cases. Among the 48 internationally imported measles cases, 33 (69%) patients were unvaccinated, one (2%) had received 1 dose of MMR vaccine, four (8%) had received 2 doses, and the vaccination status of 10 (21%) patients was unknown. All 33 of the unvaccinated persons with imported measles were age-eligible for vaccination per ACIP, including 10 infant travelers aged 6–11 months. Source countries of the 48 imported measles cases included Canada (10 cases), Vietnam (10), Mexico (seven), Pakistan (three), the Philippines (two), Saudi Arabia (two), and one imported case each from Afghanistan, Australia, Guinea, Netherlands, Somalia, Spain, and Uganda; a source country could not be determined for seven travelers who visited multiple countries during their exposure period: Tanzania and United Arab Emirates (two cases); China, Japan, and Vietnam (one); France, South Korea, and Vietnam (one); Thailand and Vietnam (one); Indonesia and the Philippines (one); and Southeast Asia (one).\n\n### Measles Outbreaks\n\nTen measles outbreaks have been reported in 2025¶¶; 751 (94%) of all reported confirmed measles cases were outbreak-associated. An imported source was identified for seven outbreaks, and the source of three outbreaks remains unknown. Outbreak-related cases have been reported in 12 states (Georgia, Indiana, Kansas, Kentucky, Michigan, New Jersey, New Mexico, Ohio, Oklahoma, Pennsylvania, Tennessee, and Texas). The largest outbreak began among a close-knit community with low vaccination coverage in Gaines County, Texas in January 2025 and has accounted for 654 (82%) cases reported during 2025 (584 patients in 24 Texas counties, 63 patients in four New Mexico counties, and seven patients in northeastern Oklahoma); the source of this outbreak remains unknown. Thirty-seven confirmed cases in Kansas are suspected to be linked to this outbreak. In addition, an expanding outbreak in Chihuahua, Mexico\\*\\*\\* began in late February after a Mexican resident became infected after reported travel to Gaines County, Texas. All 208 genotyped specimens obtained from measles patients in Kansas, New Mexico, and Texas were genotype D8, 196 (94%) of which had identical N-450 sequences; 12 differed by one nucleotide, which can be expected in prolonged outbreaks.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n## Discussion\n\nA total of 800 measles cases and 10 outbreaks were reported in the United States during the first 16 weeks of 2025, representing approximately a 180% increase over the 285 measles cases reported in the United States during all of 2024. Most cases have been associated with an ongoing outbreak in close-knit communities with low vaccination coverage in New Mexico, Oklahoma, and Texas.\n\nOverall, 11% of measles patients have been hospitalized, and three deaths have been reported. Similar to previous years ( _1_), nearly all (96%) cases occurred in persons who were unvaccinated or whose vaccination status was unknown, and 77% of cases occurred in persons who were unvaccinated when excluding cases reported by Texas. Most (92%) imported cases occurred among U.S. residents returning to the United States while infectious and from all six World Health Organization regions. Adherence to standard measles control measures, including isolation and quarantine, as well as high vaccination coverage locally, prevented secondary transmission from most of these persons who were infectious after returning from travel abroad.\n\nMost cases reported during 2025 have been associated with an ongoing outbreak in close-knit communities in New Mexico, Oklahoma, and Texas, resulting in the second largest outbreak in the United States since elimination was declared in 2000. During 2001–2023, approximately 90% of U.S. measles outbreaks with 50 or more cases occurred in close-knit communities with low vaccination coverage ( _8_). Such communities might have frequent communal gatherings and have concerns about engaging with public health and health care systems for testing, treatment, and vaccination. The United States, Canada,††† and Mexico are all experiencing large, expanding outbreaks in similar interconnected communities. Frequent travel among similar communities across multiple states and countries might facilitate the rapid spread of measles outbreaks. The risk for widespread measles transmission in the United States remains low because of high population immunity resulting from high measles vaccination coverage. However, recent increasing global measles incidence in areas frequently visited by U.S. travelers, coupled with declines in MMR vaccination coverage in many U.S. jurisdictions to <95% (the estimated population-level immunity necessary to prevent measles outbreaks), and spread of measles from ongoing domestic outbreaks to other jurisdictions, have increased the risk for ongoing measles transmission within the United States ( _8_, _9_).\n\n### Limitations\n\nThe findings in this report are subject to at least four limitations. First, imported cases were likely underreported because 30% of reported outbreaks had no known source. Second, outbreak-related cases were likely underreported because certain persons in affected communities might not engage with the health care and public health systems. Third, distinguishing unvaccinated patients from patients with unknown measles vaccination status in Texas was not possible; the Texas Immunization Registry legally requires explicit consent, or opt-in, for adults and by parent or guardian for children to enroll.§§§ Persons with no records available are considered to have an unverified vaccination history. Finally, definitive linkages between the large outbreak in New Mexico, Oklahoma, and Texas and cases reported in Kansas could not be identified.\n\n### Implications for Public Health Practice\n\nTo protect against measles and its complications before traveling internationally, all persons aged ≥12 months should have documented receipt of 2 appropriately spaced doses of MMR vaccine, and infants aged 6–11 months of age should receive 1 dose of MMR vaccine ( _10_). Persons residing in or traveling domestically to outbreak areas should follow local public health guidance, which is developed based on review and analysis of the local outbreak epidemiology ( _6_). Infants aged <6 months are at high risk for measles complications but are too young to be vaccinated, and therefore depend upon population immunity and passively transferred maternal measles antibodies (from previously vaccinated or infected mothers) to prevent infections and related complications.\n\nHealth care providers continue to serve on the front lines to identify measles cases, alert public health departments¶¶¶, ensure recommended testing, and implement measles isolation precautions to prevent health care–associated and community-based transmission. Health care providers should consider measles in the differential diagnosis for all patients (especially those who are unvaccinated) who 1) have fever (temperature ≥101°F \\[≥38.3°C\\]) and a generalized maculopapular rash with cough, coryza, or conjunctivitis, 2) have recently traveled outside the country or to a U.S. region with a known measles outbreak, or 3) have other known or suspected exposure to measles ( _6_). Although no specific Food and Drug Administration–approved antiviral therapy for measles exists, rapid access to supportive care can help relieve symptoms and treat complications such as pneumonia and secondary bacterial and viral infections. Providers should also offer and encourage vaccination for eligible patients who lack presumptive evidence of immunity to measles ( _4_).\n\nPublic health departments might benefit from using a CDC checklist\\*\\*\\*\\* to help guide their readiness activities such as preparing for laboratory testing and data reporting needs, conducting tabletop exercises, and facilitating early engagement with communities with low vaccination coverage and their trusted messengers before measles and other vaccine-preventable disease outbreaks occur. To identify communities at risk, public health departments should consider using both MMR vaccination coverage data from immunization information systems and kindergarten entry and vaccination exemption data from kindergarten entry records. Standard measles control interventions, including vaccination, isolation, quarantine, and postexposure prophylaxis (i.e., administration of MMR vaccine within 72 hours of exposure or immunoglobulin within 6 days of exposure for certain persons) ( _10_), might be challenging to implement in certain communities. Therefore, public health departments should consider partnering with trusted community messengers (e.g., clinicians and religious leaders) on culturally competent community engagement, education, vaccination efforts, and potentially acceptable community infection control approaches. Coordination with health care facilities, early childhood education facilities and schools, and other congregate settings that surround or serve these communities to prepare for measles cases regarding appropriate infection prevention and control, testing, public health follow-up, and early childhood education or school exclusion policies is crucial to limit transmission. Increasing national and local MMR vaccination coverage is essential to preventing measles cases and outbreaks.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n### Acknowledgments\n\nMichael Thomas, CDC; Sierrah Haas, Allison Zaldivar, Kansas Department of Health and Environment; Chad Smelser, New Mexico Department of Health; Anna Marie McSpadden, Ashlyn Wayman, Oklahoma State Department of Health.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\nCorresponding author: Adria D. Mathis, [amathis3@cdc.gov](mailto:amathis3@cdc.gov).\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n* * *\n\n1Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, CDC; 2ASRT, Inc., Smyrna, Georgia; 3Texas Department of State Health Services; 4New Mexico Department of Health; 5Office of the Director, National Center for Immunization and Respiratory Diseases, CDC; 6Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\nAll authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n\\\\* Two measles deaths were reported in 2003 (one in a child aged 13 years who had chronic granulomatous disease and one in an adult aged 75 years), and one was reported in 2015 in an adult with immunocompromise aged 28 years.\n\n† Measles elimination is defined as the absence of endemic measles transmission for ≥12 months in the presence of an adequate surveillance system.\n\n§ An acute febrile rash illness with laboratory confirmation (detection of measles virus–specific nucleic acid from a clinical specimen using real-time reverse transcription–polymerase chain reaction or a positive serologic test for measles immunoglobulin M antibody) or direct epidemiologic linkage to a laboratory-confirmed case.\n\n¶ For residents of Texas, vaccination history is verified in the Texas Immunization Registry (ImmTrac2) or by review of vaccination records; patients with no vaccination records in the registry were considered to have an unverified vaccination history. Texas only disaggregates unvaccinated and unknown vaccination status among hospitalized patients; these records are provider-verified.\n\n\\\\*\\\\* Epidemiologic linkages include having known or suspected contact with an infectious measles patient during the exposure period (7–21 days before rash onset) and living in or visiting a geographic area with ongoing measles transmission during the exposure period.\n\n†† Genotyping was performed at CDC and at the Vaccine Preventable Disease Reference Centers of the Association of Public Health Laboratories.\n\n§§ 45 C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq.\n\n¶¶ At the time of this report, two measles outbreaks have ended, and eight outbreaks are ongoing. A measles outbreak is considered to be over when no new cases have been identified during two incubation periods (42 days) since the rash onset in the last outbreak-related case.\n\n\\\\*\\\\*\\\\* [https://www.gob.mx/cms/uploads/attachment/file/990598/Aviso\\_Epidemiologico\\_Sarampio\\_n\\_\\_16\\_abril\\_2025.pdf](https://www.gob.mx/cms/uploads/attachment/file/990598/Aviso_Epidemiologico_Sarampio_n__16_abril_2025.pdf)\n\n††† [https://health-infobase.canada.ca/measles-rubella/](https://health-infobase.canada.ca/measles-rubella/)\n\n§§§ [https://www.cdc.gov/iis/policy-legislation/texas.html](https://www.cdc.gov/iis/policy-legislation/texas.html)\n\n¶¶¶ [https://libraries.cste.org/after-hours-contact/](https://libraries.cste.org/after-hours-contact/)\n\n\\\\*\\\\*\\\\*\\* [https://www.cdc.gov/measles/media/pdfs/2025/02/CDC-Public-Health-Checklist\\_Sept18\\_FINAL-updatedlinks-508.pdf](https://www.cdc.gov/measles/media/pdfs/2025/02/CDC-Public-Health-Checklist_Sept18_FINAL-updatedlinks-508.pdf)\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n## References\n\n01. Leung J, Munir NA, Mathis AD, et al. The effects of vaccination status and age on clinical characteristics and severity of measles cases in the United States in the postelimination era, 2001–2022. Clin Infect Dis 2025;80:663–72. [https://doi.org/10.1093/cid/ciae470](http://doi.org/10.1093/cid/ciae470) [PMID:39271123](http://www.ncbi.nlm.nih.gov/pubmed/39271123)\n02. Shattock AJ, Johnson HC, Sim SY, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet 2024;403:2307–16. [https://doi.org/10.1016/S0140-6736(24)00850-X](http://doi.org/10.1016/S0140-6736(24)00850-X) [PMID:38705159](http://www.ncbi.nlm.nih.gov/pubmed/38705159)\n03. Mina MJ, Metcalf CJ, de Swart RL, Osterhaus AD, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 2015;348:694–9. [https://doi.org/10.1126/science.aaa3662](http://doi.org/10.1126/science.aaa3662) [PMID:25954009](http://www.ncbi.nlm.nih.gov/pubmed/25954009)\n04. McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS; CDC. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62(No. RR-4):1–34. [PMID:23760231](http://www.ncbi.nlm.nih.gov/pubmed/23760231)\n05. Minta AA, Ferrari M, Antoni S, et al. Progress toward measles elimination—worldwide, 2000–2023. MMWR Morb Mortal Wkly Rep 2024;73:1036–42. [https://doi.org/10.15585/mmwr.mm7345a4](http://doi.org/10.15585/mmwr.mm7345a4) [PMID:39541251](http://www.ncbi.nlm.nih.gov/pubmed/39541251)\n06. Filardo TD, Mathis A, Raines K, et al. Measles \\[Chapter 7\\]. In: Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: US Department of Health and Human Services, CDC; 2024. [https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-7-measles.html](https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-7-measles.html)\n07. Williams D, Penedos A, Bankamp B, et al. Update: circulation of active genotypes of measles virus and recommendations for use of sequence analysis to monitor viral transmission. Wkly Epidemiol Rec 2022;97:485–92. [https://reliefweb.int/report/world/weekly-epidemiological-record-wer-30-september-2022-vol-97-no-39-2022-pp-481-492-enfr](https://reliefweb.int/report/world/weekly-epidemiological-record-wer-30-september-2022-vol-97-no-39-2022-pp-481-492-enfr)\n08. CDC. Assessing measles outbreak risk in the United States. Atlanta, GA: US Department of Health and Human Services; 2024. [https://www.cdc.gov/ncird/whats-new/measles-outbreak-risk-in-us.html](https://www.cdc.gov/ncird/whats-new/measles-outbreak-risk-in-us.html)\n09. Seither R, Yusuf OB, Dramann D, et al. Coverage with selected vaccines and exemption rates among children in kindergarten—United States, 2023–24 school year. MMWR Morb Mortal Wkly Rep 2024;73:925–32. [https://doi.org/10.15585/mmwr.mm7341a3](http://doi.org/10.15585/mmwr.mm7341a3) [PMID:39418212](http://www.ncbi.nlm.nih.gov/pubmed/39418212)\n10. CDC. Vaccines and immunizations: routine measles, mumps, and rubella vaccination. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. [https://www.cdc.gov/vaccines/vpd/mmr/hcp/recommendations.html](https://www.cdc.gov/vaccines/vpd/mmr/hcp/recommendations.html)\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n##### [![Return to your place in the text](https://www.cdc.gov/images/arrow_up.gif)](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm\\#F1_up)**FIGURE 1**. **Reported number of confirmed\\* measles cases, by state (N = 800) — United States, January 1–April 17, 2025**\n\n![The figure is a map of the United States illustrating the reported number of confirmed measles cases, by state, during January 1–April 17, 2025.](https://www.cdc.gov/mmwr/volumes/74/wr/figures/mm7414a1-F1_Measles_Update-medium.gif?_=26551)\n\n\\\\* An acute febrile rash illness with laboratory confirmation of measles or a direct epidemiologic link to a laboratory-confirmed measles case.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n##### [![Return to your place in the text](https://www.cdc.gov/images/arrow_up.gif)](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm\\#F2_up)**FIGURE 2**. **Number of reported confirmed\\* measles cases, by week of rash onset and importation status (N = 800) — United States, January 1–April 17, 2025†**\n\n![The figure is a histogram of the number of reported confirmed measles cases in the United States, by week of rash onset and importation status, during January 1–April 17, 2025.](https://www.cdc.gov/mmwr/volumes/74/wr/figures/mm7414a1-F2_Measles_Update.gif?_=26554)\n\n\\\\* An acute febrile rash illness with laboratory confirmation of measles or a direct epidemiologic link to a laboratory-confirmed measles case.\n\n† Data are preliminary as of April 17, 2025. Data for the week ending April 19, 2025, are for a partial week.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n| Characteristic | No. of measles cases (%) |\n| :-- | :-: |\n| Total | International importations | U.S.-acquired |\n| :-: | :-: | :-: |\n| **Total measles cases** | **800 (100)** | **48 (6)** | **752 (94)** |\n| **Age group, yrs** |\n| <5 | **249 (31)** | 17 (35) | 232 (31) |\n| 5–19 | **304 (38)** | 6 (13) | 298 (40) |\n| ≥20 | **231 (29)** | 22 (46) | 209 (28) |\n| Unknown | **16 (2)** | 3 (6) | 13 (2) |\n| **Measles vaccination status** |\n| Unvaccinated or unknown | **771 (96)** | 43 (90) | 728 (97) |\n| Vaccinated, 2 doses | **19 (2)** | 4 (8) | 15 (2) |\n| Vaccinated, 1 dose | **10 (1)** | 1 (2) | 9 (1) |\n| **Measles vaccination status (excluding Texas residents)** |\n| Unvaccinated | **162 (77)** | 30 (68) | 132 (80) |\n| Unknown | **30 (14)** | 9 (20) | 21 (13) |\n| Vaccinated, 2 doses | **12 (6)** | 4 (9) | 8 (5) |\n| Vaccinated, 1 dose | **6 (3)** | 1 (2) | 5 (3) |\n| **Residency** |\n| U.S. resident | **790 (99)** | 44 (92) | 746 (99) |\n| **Outcome** |\n| Hospitalized | **85 (11)** | 15 (31) | 70 (9) |\n| Died† | **3 (3.8)** | 0 (—) | 3 (4.0) |\n| **Vaccination status of hospitalized patients**§ |\n| Unvaccinated | **56 (66)** | 11 (73) | 45 (64) |\n| Unknown | **28 (33)** | 3 (20) | 25 (36) |\n| Vaccinated, 1 dose | **1 (1)** | 1 (7) | 0 (—) |\n\n##### **TABLE. Selected characteristics of patients with reported measles — United States, January 1–April 17, 2025\\*** [![Return to your place in the text](https://www.cdc.gov/images/arrow_up.gif)](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm\\#T1_up)\n\n\\\\* Data are preliminary as of April 17, 2025.\n\n† Deaths per 1,000 persons with measles.\n\n§ Percentage among all hospitalized patients.\n\n[Top](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm#)\n\n**Suggested citation for this article:** Mathis AD, Raines K, Filardo TD, et al. Measles Update — United States, January 1–April 17, 2025. MMWR Morb Mortal Wkly Rep 2025;74:232–238. DOI: [http://dx.doi.org/10.15585/mmwr.mm7414a1](http://dx.doi.org/10.15585/mmwr.mm7414a1).\n\n_MMWR_ and _Morbidity and Mortality Weekly Report_ are service marks of the U.S. Department of Health and Human Services.\n\nUse of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of\nHealth and Human Services.\n\nReferences to non-CDC sites on the Internet are\nprovided as a service to _MMWR_ readers and do not constitute or imply\nendorsement of these organizations or their programs by CDC or the U.S.\nDepartment of Health and Human Services. CDC is not responsible for the content\nof pages found at these sites. URL addresses listed in _MMWR_ were current as of\nthe date of publication.\n\nAll HTML versions of _MMWR_ articles are generated from final proofs through an automated process.\nThis conversion might result in character translation or format errors in the HTML version.\nUsers are referred to the electronic PDF version ( [https://www.cdc.gov/mmwr](https://www.cdc.gov/mmwr))\nand/or the original _MMWR_ paper copy for printable versions of official text, figures, and tables.\n\nQuestions or messages regarding errors in formatting should be addressed to\n[mmwrq@cdc.gov](https://www.cdc.gov/mmwr/form/index.html).\n\nView Page In: [Article PDF](https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7414a1-H.pdf) [Full Issue PDF](https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7414-H.pdf)\n\nLast Reviewed: April 24, 2025\n\nSource: [Centers for Disease Control and Prevention](https://www.cdc.gov/)\n\nSASstats",
    "query": "measles misdiagnosis rubella USA 2025"
  },
  {
    "snippet": "[Skip to content](https://historyofvaccines.org/blog/return-measles-global-health-crisis-unfolding-2025#main-content)\n\nUpdates regarding our human remains policy.\n\n[click here](https://muttermuseum.org/mutter-matters)\n\n[Blog](https://historyofvaccines.org/blog)\n\n# The Return of Measles: A Global Health Crisis Unfolding in 2025\n\nBy\n\nRené F. Najera, DrPH\n\nSeptember 30, 2025\n\nMeasles, once nearly eliminated in many parts of the world, has made a dangerous comeback in 2025. This highly contagious di...",
    "content": "[Skip to content](https://historyofvaccines.org/blog/return-measles-global-health-crisis-unfolding-2025#main-content)\n\nUpdates regarding our human remains policy.\n\n[click here](https://muttermuseum.org/mutter-matters)\n\n[Blog](https://historyofvaccines.org/blog)\n\n# The Return of Measles: A Global Health Crisis Unfolding in 2025\n\nBy\n\nRené F. Najera, DrPH\n\nSeptember 30, 2025\n\nMeasles, once nearly eliminated in many parts of the world, has made a dangerous comeback in 2025. This highly contagious disease has spread rapidly across continents, affecting both developing nations struggling with poverty and conflict, and wealthy countries where vaccination rates have declined. Understanding what’s happening worldwide helps us see how interconnected our global health really is.\n\n###### A Global Picture of Concern\n\nWhen we examine measles today, we see a story that spans from remote villages in Afghanistan to suburban communities in Texas. The numbers tell a sobering tale: globally, an estimated [10.3 million people were infected with measles](https://www.cdc.gov/global-measles-vaccination/data-research/global-measles-outbreaks/index.html) in 2023, and 2025 has brought even more cases. What makes this particularly troubling is that measles is entirely preventable through vaccination.\n\nMeasles spreads through the air when an infected person coughs or sneezes. It’s so contagious that if one person has measles, up to 90% of the people around them who aren’t immune will also contract the infection. The disease begins with symptoms that may resemble a cold or flu-like illness: fever, cough, runny nose, and red, watery eyes. Then comes the telltale rash, spreading from the head down to the feet. But measles isn’t just an uncomfortable childhood illness. It can cause serious complications, including brain swelling, pneumonia, and death, particularly in young children and adults.\n\n###### The Devastating Toll in Developing Nations\n\nThe hardest-hit regions in 2025 have been countries already struggling with poverty, conflict, and weak healthcare systems. In [Morocco, over 40,000 cases and 184 deaths](https://outbreaknewstoday.substack.com/p/morocco-measles-cases-top-40000-in) have been reported, making it one of the world’s most severe outbreaks. The situation became so dire that Morocco launched a nationwide vaccination campaign targeting everyone under 18 years old.\n\nIn Afghanistan, where healthcare has collapsed following years of conflict, [Doctors Without Borders recorded at least one child dying from measles every single day](https://www.msf.org/msf-records-one-child-died-measles-each-day-2025-afghanistan) during the first eight weeks of 2025. Their medical teams treated nearly 5,000 suspected measles cases at just three hospitals during this short period. This represents a heartbreaking increase compared to 2024, showing how quickly measles can spread in vulnerable populations.\n\nIndonesia faced its own crisis when [17 children died](https://www.pbs.org/newshour/world/after-17-die-in-measles-outbreak-indonesia-launches-vaccination-campaign) during a measles outbreak in East Java province. More than 2,000 children became infected over eight months, prompting authorities to launch an emergency vaccination campaign. The outbreak highlighted how vaccination coverage of just 72% nationally, with some provinces below 50%, leaves children dangerously exposed.\n\nAfrica has seen widespread outbreaks across multiple countries. The Democratic Republic of Congo reported [over 36,000 suspected cases and 565 deaths](https://www.doctorswithoutborders.ca/democratic-republic-of-congo-in-the-shadow-of-conflict-msf-teams-are-chasing-disease-outbreaks/) across nearly all of its 26 provinces by July 2025. Somalia, Sudan, Yemen, and other nations in the Eastern Mediterranean region have also experienced large outbreaks, with eight countries in this region alone reporting approximately 105,000 confirmed cases between July 2024 and June 2025.\n\nThe Western Pacific region saw a [743% increase in measles cases](https://www.who.int/westernpacific/news/item/28-05-2025-resurgence-of-preventable-diseases-threatens-children-in-east-asia-and-the-pacific) between 2022 and 2024, with the crisis continuing into 2025. Vietnam recorded over 81,000 suspected cases across all its provinces, while Mongolia reported 8 deaths and hundreds of hospitalizations.\n\n###### Europe’s Unexpected Struggle\n\nPerhaps more surprising has been Europe’s battle with measles in 2025. The European region, which includes 53 countries from Western Europe to Central Asia, experienced its [worst measles year in over 25 years](https://www.who.int/europe/news/item/13-03-2025-european-region-reports-highest-number-of-measles-cases-in-more-than-25-years---unicef--who-europe), with 127,350 cases reported in 2024, and the crisis continued into 2025.\n\nRomania has been particularly affected, reporting [3,605 infections and three deaths](https://www.euronews.com/health/2025/06/03/measles-in-europe-where-are-cases-of-one-of-the-most-contagious-diseases-rising) through April 2025. The country’s outbreak has been driven by anti-vaccine sentiment, conflicting health guidance, and healthcare system challenges. With vaccination rates at just 62% in 2023, far below the 95% needed to prevent outbreaks, Romania illustrates how quickly measles can take hold when vaccination coverage drops.\n\nAcross Europe, the story is similar. Countries like Austria, Cyprus, France, Germany, the Netherlands, and Portugal have all reported ongoing outbreaks. The United Kingdom has seen cases [picking up again in England](https://www.gov.uk/government/news/measles-outbreaks-continue-with-risk-of-holidays-causing-surge), with health officials warning travelers about the risk of bringing measles back from European vacation destinations.\n\nThe European Centre for Disease Prevention and Control found that [87% of measles patients were unvaccinated](https://www.vax-before-travel.com/measles-outbreaks), highlighting how the disease primarily affects those without protection. Vaccination rates across Europe have struggled to return to pre-pandemic levels, with coverage of the second MMR dose [declining from 92% to 91%](https://www.who.int/europe/news/item/15-07-2025-childhood-vaccination-rates-lag-in-europe---fueling-further-resurgence-of-measles-and-whooping-cough) between 2019 and 2024.\n\n###### The United States Faces Its Largest Outbreak in Decades\n\nThe United States, which declared measles eliminated in 2000, experienced its [largest outbreak in over 30 years](https://www.politico.com/news/2025/07/09/the-2025-measles-outbreak-is-largest-in-three-decades-00444186) in 2025. As of late September, [1,514 confirmed measles cases](https://www.cdc.gov/measles/data-research/index.html) have been reported across 42 states, with 40 outbreaks recorded throughout the year.\n\nThe majority of U.S. cases stem from a massive outbreak that began in January 2025 in close-knit communities across New Mexico, Oklahoma, and Texas. By April, this single outbreak had caused [654 of the 800 total U.S. cases](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm) reported at that time. The outbreak affected communities with low vaccination rates and frequent travel between similar communities across multiple states.\n\nThe human cost has been severe. [Twelve percent of patients required hospitalization](https://www.cdc.gov/measles/data-research/index.html), with nearly a third of those hospitalized being children and teenagers. Three people have died from measles in the United States in 2025, including two unvaccinated school-aged children in Texas and one unvaccinated adult in New Mexico.\n\nWhat’s particularly concerning is that [92% of U.S. measles patients were either unvaccinated or had unknown vaccination status](https://www.cidrap.umn.edu/measles/cdc-confirms-23-more-us-measles-cases-2025-total-tops-1500). This pattern mirrors what we’re seeing globally: measles primarily affects those who haven’t been protected by vaccination.\n\n###### North America’s Measles Crisis: Mexico and Canada Lead the Way\n\nMexico has emerged as one of North America’s most severely affected countries in 2025, with [over 4,200 confirmed measles cases and 15 deaths](https://outbreaknewstoday.substack.com/p/mexico-reports-15th-measles-death) reported as of late August. The outbreak has been concentrated primarily in Chihuahua state, which borders Texas and accounts for [nearly 93% of Mexico's cases](https://www.wired.com/story/measles-cases-are-soaring-in-mexico/) with 3,932 infections. The crisis began when [a 9-year-old Mennonite child](https://www.thinkglobalhealth.org/article/measles-takes-root-mexico) returned from a family trip to Texas, where measles was already circulating. Tragically, most deaths have occurred among indigenous communities, which have experienced [a case-fatality rate 20 times higher](https://www.cidrap.umn.edu/measles/measles-surge-continues-americas-outbreaks-10-nations) than the general population. The rapid spread has been attributed to low vaccination coverage and frequent travel between under-vaccinated religious communities that span across international borders.\n\nCanada's situation is equally concerning, with [over 4,500 confirmed cases](https://www.paho.org/en/news/15-8-2025-ten-countries-americas-report-measles-outbreaks-2025) making it the country with the highest measles count in the Americas in 2025. Despite having achieved measles elimination status in 1998, Canada has reported [more cases this year than in the previous 27 years combined](https://www.cnn.com/2025/06/06/health/measles-deaths-canada-mexico). The outbreak has been particularly devastating for vulnerable populations, with [one infant death from congenital measles](https://www.bmj.com/content/389/bmj.r1207) reported when a premature baby was born to an unvaccinated mother in Ontario. Six other babies have been born with congenital measles in Ontario alone, though they have since recovered. The outbreak began in October 2024 when an internationally imported case attended a large gathering in New Brunswick, and it has since spread to multiple provinces. Public health officials warn that if transmission continues beyond October 2025, [Canada could lose its measles elimination status](https://www.canada.ca/en/public-health/services/emergency-preparedness-response/rapid-risk-assessments-public-health-professionals/public-health-risk-assessment-measles.html), a designation it has maintained for over two decades.\n\n###### Why Measles Is Making This Comeback\n\nThe resurgence of measles in 2025 is a result of several converging factors. The COVID-19 pandemic disrupted routine childhood vaccination programs worldwide, leaving millions of children without protection. In 2023 alone, [500,000 children across the European region](https://www.vaccinestoday.eu/stories/us-measles-death-is-europe-protected/) missed their first dose of the measles vaccine.\n\nVaccine hesitancy, fueled by misinformation spread through social media, has taken root in communities around the world. In Morocco, [conspiracy theories that gained traction during COVID-19](https://maghrebi.org/2025/01/31/morocco-conspiracy-theories-blamed-for-measles-outbreak/) have been blamed for the current outbreak. Similar patterns of vaccine hesitancy have contributed to outbreaks in wealthy countries where high vaccination coverage was once the norm.\n\nGlobal conflict and instability have created perfect conditions for measles to spread. In countries like Afghanistan, Yemen, and the Democratic Republic of Congo, ongoing conflicts have devastated healthcare systems and displaced populations, making vaccination campaigns nearly impossible to implement effectively.\n\nInternational travel has also played a role. Most [imported U.S. cases occurred among residents returning from travel abroad](https://www.cdc.gov/mmwr/volumes/74/wr/mm7414a1.htm), bringing measles back from all six World Health Organization regions. As global measles cases rise, the risk of international spread increases.\n\n###### The Path Forward\n\nThe good news is that measles remains entirely preventable through vaccination. The MMR vaccine (protecting against measles, mumps, and rubella) is safe, effective, and has been used successfully for decades. Two doses of the vaccine provide about 97% protection against measles.\n\nCountries are responding with targeted vaccination campaigns. Indonesia launched drives to reach 78,000 children, while Morocco implemented nationwide catch-up vaccination for everyone under 18. Health officials worldwide are working to rebuild public trust in vaccines and counter misinformation with factual, science-based information.\n\nFor individuals, the message is clear: check your vaccination status and that of your family members. If you’re unsure whether you’ve received two MMR doses, contact your healthcare provider. It’s never too late to get vaccinated, and doing so not only protects you but also helps protect your community, especially those who cannot be vaccinated due to medical conditions.\n\nThe 2025 measles crisis serves as a stark reminder that infectious diseases don’t respect borders. What happens in one part of the world can quickly affect communities thousands of miles away. By maintaining high vaccination coverage everywhere, we can prevent measles from continuing its devastating global spread and protect the most vulnerable members of our communities.\n\nThe tools to end this crisis exist. What’s needed now is the collective will to use them, rebuild vaccination programs, and ensure that no child dies from a completely preventable disease. The story of measles in 2025 doesn’t have to continue being one of tragedy—it can become one of renewed commitment to global health and protection for all children.\n\n## Tags\n\n- [Africa](https://historyofvaccines.org/blog/tags/africa),\n- [Asia](https://historyofvaccines.org/blog/tags/asia),\n- [Epidemiology](https://historyofvaccines.org/blog/tags/epidemiology),\n- [Europe](https://historyofvaccines.org/blog/tags/europe),\n- [North America](https://historyofvaccines.org/blog/tags/north-america),\n- [Public Health](https://historyofvaccines.org/blog/tags/public-health-0),\n- [South America](https://historyofvaccines.org/blog/tags/south-america),\n- [Vaccines for Children](https://historyofvaccines.org/blog/tags/vaccines-children),\n- [Viral Disease](https://historyofvaccines.org/blog/tags/viral-disease),\n\n## Related\n\nTwitter Widget Iframe",
    "query": "measles misdiagnosis rubella USA 2025"
  }
]